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1. Introduction
Skeletal muscle tissue engineering is a field of research focusing 
on the development of engineered skeletal muscle tissues 
(SMTs) in vitro.[1] The field of skeletal muscle tissue engineering 
has advanced in recent years by moving away from the use of 
standard 2D culture plates and steadily incorporating new param-
eters to recapitulate the native tissue’s microenvironment.[2,3] 
Engineering functional skeletal muscle tissue is an ongoing challenge 
because of the complexity of the in vivo microenvironment and the various 
factors that contribute to the development and maintenance of the native 
tissue. However, the growing understanding of the natural skeletal muscle’s 
microenvironment in vivo, as well as the ability to successfully reproduce 
these factors in vitro, are contributing to the formation of engineered skeletal 
muscle tissues (SMTs) with greater biomimetic structure and function. This 
review first summarizes the structure of skeletal muscle tissue. The role of 
various hydrogels, biomaterials, and scaffolds as building blocks of complex 
skeletal muscle structures is then explored. Additionally, the role of external 
stimuli and regulators that can be applied during in vitro culture that lead to 
the formation of SMT models with higher functionality is examined. These 
include various physical, biochemical, electrical, mechanical, and magnetic 
stimulations, as well as biological stimulation through coculture with fibro-
blasts, endothelial, or neuronal cells. Finally, examples of recently developed 
functional tissue models that have been developed for in vitro and in vivo 
applications and the future outlook for this field are discussed.
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This has led to the identification of various 
factors that are biochemically relevant to 
the skeletal muscle microenvironment 
which guide specific cellular behaviors 
such as targeted cell growth, differentia-
tion, and maturation.[4] A wide variety of 
parameters have been used to effectively 
guide cell behavior and tissue formation, 
such as the types of cells that are used, 
properties of the biomaterials, topography 
of the cell culture substrate, and methods 
of stimulations. Furthermore, the combi-
nation of the aforementioned parameters 
can cooperatively lead to the formation 
of sophisticated skeletal muscle models. 
This review will first summarize the tissue 
structure of skeletal muscle, describe the 
natural maturation process of the tissue, 
and elucidate the importance of engi-
neering SMT in vitro. Next, the technolo-
gies used to achieve the tissue engineering 
of skeletal muscle—from one to four-
dimensions—will be reviewed, and the 
level of the maturation and functionality of the engineered SMTs 
will be compared. Finally, we will discuss the effects of various 
external stimuli and regulators that are prominent in contempo-
rary SMT engineering, and describe how they influence a tissue 
model’s formation, maturation, and functionality.
2. Skeletal Muscle Tissue
Skeletal muscle tissue is a prime example of why anatomy and 
physiology are traditionally taught in tandem; the form of the 
SMT is absolutely crucial for the appropriate function of the 
organ itself. Any damage to this structure will have immediate 
and detrimental effects on the function of the muscular system. 
In order to understand how to engineer functional SMT, it is 
important to understand how the muscle is formed and regu-
lated in the body naturally, including how the body’s natural 
attempts at healing damaged or diseased muscles often fall 
short in restoring functional muscle tissue.
2.1. Structure of Skeletal Muscle Tissue
Skeletal muscle tissue has a highly ordered, hierarchical struc-
ture. The highest order of this structure is the muscle itself, 
© 2020 The Authors. Advanced Materials Interfaces published by Wiley-
VCH GmbH. This is an open access article under the terms of the Crea-
tive Commons Attribution License, which permits use, distribution and 
reproduction in any medium, provided the original work is properly cited.
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which consists of a bundle of fascicles combined together under 
the epimysium, a sheath of connective tissue. Each one of these 
fascicles are themselves a bundle of muscle fibers, also known 
as myofibers. A single myofiber is a long, multinucleated 
muscle cell; it is the muscle cell structure that imbues the skel-
etal muscle tissues with their ability to contract along a single 
uniaxial direction. The bundle structure of the organ allows the 
myofibers to be aligned parallelly in a single direction, thereby 
maximizing the strength of their contraction (Figure 1A).[5]
Importantly, the differentiated adult myofibers are incapable of 
undergoing mitosis.[5] Any fibers that are lost due to damage or 
disease must be replaced via a precursor cell, known as a myo-
blast.[8,9] Each myofiber has a supportive scaffolding structure 
around it called the basal lamina. Inside the basal lamina resides 
a population of progenitor cells, or satellite cells, that maintain the 
myoblast population through proliferation and subsequent differ-
entiation. Satellite cells are a major component of the body’s mus-
cular maintenance system, and are frequently activated to replace 
any lost myofibers. Myoblasts are mononucleated cells that, under 
the appropriate external stimuli, will undergo differentiation by 
fusing with other myoblasts until they form a single, multinucle-
ated myofiber (Figure 1B). During repair, the satellite cell-derived 
myoblasts typically differentiate by fusing to existent secondary 
fibers, thereby increasing their size and regaining lost function-
ality of the tissue.[8,10] Through this process, the body can maintain 
and regulate the size and shape of the skeletal muscles over time.
The functional capabilities of the myofibers are derived 
from internal structures comprised of specific populations of 
specialized proteins.[11] These proteins form long parallel fibrils 
inside the muscle cells, with repeating functional units termed 
sarcomeres that are arranged along the length of these bands. 
Each sarcomere starts and ends with a band of proteins known 
as the Z-disc. In between each Z-disc, thin filaments made up 
of actin are arranged forming a type of backbone around a core 
of thick filaments comprised of the protein myosin. As myosin 
and actin bind together, the thin filaments are dragged across 
the thick filaments, and the sarcomere itself contracts. With 
these smallest of actions, these proteins provide the basis for 
the skeletal muscle’s critical functions.[5,8,11]
Myofibers utilize mechanotransduction pathways to regu-
late their functional characteristics. Muscle cells are capable of 
detecting mechanical signals from their environment through 
the use of transmembrane proteins known as integrins. Inte-
grins form the attachment points between the intracellular 
cytoskeleton and the extracellular matrix (ECM). Mechanotrans-
duction is the process by which mechanical signals such as 
matrix stiffness or shear stress are translated into chemical 
responses by cells. Integrins can be recruited together to form 
complex transmembrane bundles known as focal adhesions.[12] 
These complexes are crucial for the amplification and down-
stream signaling of external mechanical stimuli.[13] They have 
a direct impact on the remodeling of the actin cytoskeleton, 
which affects the mechanical properties and behaviors of the 
myofibers themselves. In recent years, scientists have mapped 
out the mechanotransduction pathways with a certain degree 
of success.[13,14] These pathways, and similar pathways derived 
Figure 1. The structure and development of skeletal muscle tissue. A) The hierarchical structure of skeletal muscle, wherein fibers are bundled together 
in increasingly larger fascicles, provide the isotropic form necessary for the specific functions of skeletal muscle. Adapted under the terms of a Creative 
Commons Attribution 4.0 International License.[6] Copyright 2020, MDPI. B) The specialization of myoblasts from satellite cells are characterized by 
the appearance of paired box 5 (Pax5) and paired box 7 (Pax7). The differentiation of those cells from myoblasts into myotubes are characterized by 
Myf5, MyoD, and Myogenin. Finally, matured myofibers are characterized as fully functional upon the expression of MHC and Mrf4. Adapted under 
the terms of a Creative Commons Attribution 4.0 International License.[7] Copyright 2018, MDPI.
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from other forms of stimulation such as electrical or chemical, 
result in the increased expression and activation of several pro-
teins that have been noted for their specific importance in the 
regulation of the formation of functional muscle tissue, as well 
as for their role in the conversion of MHC from one isoform to 
another.[14a] In this review the effect of the other stimulations 
will be discussed in detail.
2.2. Development of Muscular Phenotypes
Skeletal muscles are similar in structure but can vary widely in 
both size and strength. Their sizes and strengths are important 
phenotypic characteristics, but what anatomical explanation is 
there for their variety in a single individual? The answer is found 
among the proteins of the sarcomere, which dictate its func-
tional characteristics. One of the most important proteins for 
defining the structural and functional phenotype of the myofiber 
is myosin. Structurally, myosin has two globular head units with 
tails that curl around each other in an α-helical structure.[15] A 
single head unit with its single tail is known as myosin heavy 
chain (MHC). There are a variety of isoforms or versions of 
MHC that correspond to several different myofibril phenotypes, 
which appear at different stages of muscle growth and develop-
ment.[15] For example, MHC-emb and MHC-neo appear during 
the embryonic and neonatal stages of life, respectively, while 
m-MHC is found only in the mandibular regions of the body 
and cardiac-α MHC is found primarily in cardiac muscle cells.[16] 
In skeletal muscle cells, the MHC isoforms can be character-
ized by their unique ATPase activity, which in turn affects other 
downstream phenotypic attributes such as contraction velocity 
and resistance to fatigue.[14a] Each isoform is vital in determining 
the metabolic activity of the myofibril, which likewise affects the 
contractile behavior of the muscle cell itself.[15–17]
In the process of muscle formation, the existence of MHC 
isoforms is very important. Certain isoforms appear only in 
specific phases of one’s life. MHC-emb is the MHC protein pri-
marily found only during the embryonic phase of muscle for-
mation.[18] This is the phase in which the embryonic myoblasts 
differentiate to form primary myofibers by fusing together. 
These myofibers are smaller in size than adult myofibers, as 
they are made up of a lower number of myoblasts in the early 
stages of muscle formation. It has been suggested that the 
reason that primary myofibers exist is to form the muscle pat-
tern for the body to build upon.[8] After the muscle pattern has 
been laid down, fetal/neonatal myogenesis occurs. Neonatal 
myoblasts undergo differentiation by fusing to the primary 
myofibers directly, creating secondary myofibers.[8,16] Secondary 
myofibers follow the same shape and muscle pattern as the 
primary myofibers, but with noticeably larger fiber diame-
ters and higher contractile force capabilities derived from the 
higher number of nuclei. In the first month of development, 
these myofibers express primarily MHC-neo, with a relatively 
smaller population of MHC-emb.[16] However, the myofibers 
quickly grow in mass and in functional strength, and the MHC 
isoforms likewise change to those associated with the adult 
myofibers.[8,14a,16]
Adult myofibers contain sarcomeres with varying propor-
tions of the different MHC isoforms, dependent on the location 
of the muscle and the various external stimuli it is subjected 
to. The most common MHC isoforms in adult skeletal muscle 
are slow type I, fast type IIa, fast type IIb, and fast type IIx.[16] 
Each MHC isoform functions slightly differently; muscles with 
predominantly slow type I isoforms are classified as “slow-
twitch” fibers and are typically resistant to fatigue.[15] Muscles 
that primarily contain type IIx and type IIb isoforms are classi-
fied as “fast-twitch” fibers, due to their fast contraction speeds 
and their glycolytic metabolic pathways.[15] These phenotypic 
differences at the protein level create functionally and structur-
ally different adult myofibers, thereby affecting the phenotype 
of the tissue itself. Researchers have thus begun measuring 
the MHC composition of the sarcomeres as a method of deter-
mining the phenotype of the myofiber, which can be applicable 
both for tissue explanted from a patient and tissue grown in 
vitro.[8]
2.3. Markers of Myogenic Differentiation
There are a few myogenic regulatory factors (MRFs) that are 
crucial for the appropriate proliferation and differentiation of 
myoblasts into myofibers. The four key MRFs are known as 
Myf5, MyoD, Mrf4, and Myogenin.[8] They are proteins pri-
marily involved in transcriptional regulation of myogenesis.[17] 
By analyzing the presence of these proteins in groups of myo-
blasts or myofibers in vivo or in vitro, researchers are able to 
determine whether the cells are expressing the MRFs associ-
ated with mature, functional myofibers.[8] For example, Myf5 
and MyoD are expressed by un-differentiated myoblasts prior 
to fusion, whereas Myogenin is significantly up-regulated in 
functional myofibers.[8] MyoD and Myf5 are not expressed after 
differentiation, as they are partially required for cell cycle regu-
lation, which is unnecessary for the post-mitotic myofibers. 
Myogenin and Mrf4 are indicative of the successful fusion 
of myoblasts into myotubes and the formation of myofibrils 
respectively, with further myofiber maturation confirmed via 
the presence of MHC.[19]
The complexity of the natural regulatory pathways for skel-
etal muscle tissue cannot be overstated; there is a wide range of 
environmental cues that up-regulate and down-regulate specific 
genes in order to create an organic muscular “tapestry”, which 
is woven together with fibers comprised of various proportions 
of MHC proteins. The summation of all of the various iso-
forms results in a final, hybrid fiber with a net phenotype that 
is dependent on the relative proportions of those isoforms.[11] 
This structure is constantly changing as the body adapts to new 
loading regimes and electrical/hormonal changes, and as it 
tries to repair any fibers lost to damage or disease.
2.4. Diseased and Injured States
There are many different types of damage that muscle tissue 
can undergo during its lifetime, from temporary strains that 
decrease function over a short period of time to more intense 
tears that can permanently disable a muscle’s ability to con-
tract.[20] Due to the prevalence of sports and physical activities, 
as well as potential traumatic events in the average person’s 
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lifetime, muscle injuries can be quite widespread.[21] For the 
majority of cases, a simple treatment consisting of rest and 
light rehabilitation can give the muscle tissue the environment 
it requires to naturally repair itself.[20b,21b] As with most types 
of tissue damage, complications can and do arise that require 
a more coordinated and direct method of intervention and 
treatment.[20b] Ramos et  al.[20b] described three categories of 
specific damage to muscle tissues that would typically require 
surgery; i) severe muscle hematoma, ii) myositis ossificans, and 
iii) compartment syndrome. The first two categories can still be 
treated non-operatively in their mild phases, with surgery used 
only in the most severe of cases. The last category, compart-
ment syndrome, will require surgery immediately upon diag-
nosis to save the tissues. Skeletal muscle tissue can self-renew 
up to a point, after which the damaged tissue is instead replaced 
by non-functional scar tissue.[20b] The loss of functional muscle 
fibers and their replacement with fibrotic scar tissue is a key 
characteristic of volumetric muscle loss (VML).[22] If a muscle 
suffers from more than a 20% loss in muscle volume, then it is 
seen as irreparable by traditional surgical methods.[20b] Current 
therapies, aimed at breaking the 20% VML replacement barrier, 
include complex autografts of existing muscle flaps and similar 
transplants, which are not optimal considering their induced 
donor site morbidity as well as their functional limitations.[22]
The ageing process also has a tremendous effect on the 
development and maintenance of SMT. Natural muscle 
atrophy, also known as sarcopenia, occurs past 50 years of age 
in most humans and is associated with a decrease in the total 
number of muscle fibers as well as a decrease in the fiber diam-
eters. These morphological changes contribute to a lower total 
strength of the muscle.[23] With a growing elderly population 
in many developed countries, and the crucial role of muscle 
strength in mobility and quality of life, muscle repair becomes 
an increasingly pressing issue to tackle.
Unfortunately, sarcopenia can be exacerbated by various 
diseases. Cancer patients, for example, can experience an 
advanced form of muscle atrophy known as cachexia. The total 
volume loss of the affected muscles ranges from 20% to 70% 
on average, depending on the type and stage of the cancer.[24] 
Some of the many side-effects of the treatment of cancer, such 
as the decrease of food intake and physical activity as well as 
the increasing resting energy expenditure (REE) of skeletal 
muscle, lead to this environment of rapid muscle degeneration.
Altogether, cachexia accounts for 20–30% of all cancer-
related deaths and is currently treated through physical therapy, 
while better treatments and interventions are being pursued 
via limited drug trials.[23a,24–25] Duchenne’s Muscular Dystrophy 
(DMD) is a similarly debilitating disease in which the skeletal 
muscle cells lack the key dystrophin gene, leading to a constant 
cycle of muscular degeneration and regeneration that causes 
acute muscular atrophy.[26] For all the advancements in cell 
therapies, the resources available to clinicians are still insuf-
ficient to reverse many of the symptoms presented in cancer 
cachexia and DMD.[9] The tissue engineering of skeletal muscle 
is attractive due to its potential for the production of biologically 
relevant myofibers in vitro. However, the tissue engineering 
of skeletal muscle and the development of more mature and 
functional tissues in vitro remains a distinct challenge for 
researchers today. Tissue engineers are working to learn more 
about the natural and diseased regulatory pathways in order 
to better design intervention strategies for the promotion of 
healthy, functional SMT. In the next section, we review the 
current state of SMT engineering from a new perspective and 
based on the various culture strategies used in bottom-up and 
top-down tissue engineering approaches (Figure 2).
3. Tissue Engineering Skeletal Muscle Tissue
Various tissue-engineering strategies have been introduced to 
engineer skeletal muscles with similar structure and function-
ality as a native tissue. In tissue engineering, mimicking the 
ECM is one of the major challenges currently addressed by var-
ious approaches. In the traditional, “top-down” approach intro-
duced in 1959 by Feynman,[28] tools are used which can sculpt 
an object in different scales, such as photolithography. Later, 
Drexler[29] introduced the nano-manufacturing approach called 
the “bottom-up” approach, which focuses on fabrication of 
tissue structures from building blocks in microscale.[30] Most of 
the examples seen in regenerative medicine that deal with the 
production of a scaffold in a mold are examples of a top-down 
strategy; here, scaffolds are used to promote the pre-alignment 
of the muscle cells, while also promoting the anisotropic ori-
entation of the differentiated myofibers after the fusion of the 
muscle cells.[31] While it is possible to inject muscle cells at the 
site of the injury or to transplant a blank scaffold, transplanting 
a cell-laden scaffold is a more promising strategy.[2,31a] The treat-
ment of skeletal muscle tissues using intramuscular injection 
of cells results in poor therapeutic outcomes. The main limita-
tions can be attributed to immune reactions, low cell integra-
tion into the host tissue, as well as patient discomfort and risk 
of infection. To avoid these issues, soft carriers can be used to 
locally deliver cells, or cell-encapsulated scaffolds can be used 
as an alternative to increase the efficiency of cell delivery at the 
injury site.[32] Preferably, scaffolds will mimic the native ECM 
with appropriate biophysical and biochemical cues[33] . In the 
bottom-up approach, the formation of the construct relies on 
the self-assembly or directed-assembly of a scaffold from small 
modules and components, with microscale precision; this 
allows the construct to be designed to carry out distinct tasks. 
In this case, it is possible to fabricate complex structures mim-
icking the target tissue structure. Various techniques have been 
employed to produce these microscale building units without 
biomaterials or cells, such as the development of cell sheets,[34] 
self-assembly of cells and cell aggregates,[35] microgels,[36] 
microfabrication of cell encapsulated hydrogels[30b] and 3D 
bioprinting.[30c,37] As with any other engineering process, it is 
easiest to describe the ideas behind 3D scaffolds by first com-
paring and contrasting how each dimension plays a part in the 
structure of native skeletal muscle.
3.1. 1D and 2D Engineered Muscle Tissue
The unidirectional organization of the muscle fibers, an essen-
tial characteristic of the muscle tissue structure, has always 
been the first focus in imitating the functionality of that 
structure. Therefore, treating individual short and long fibers as 
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1D systems was effective in initiating the necessary alignment, 
due to the effect of the topography induced onto the cells by the 
axis of the fibers. Using short fragments in the form of inject-
able ribbons we showed that cell-laden, 1D ribbons can effec-
tively support the attachment of mouse muscle cells and their 
subsequent differentiation, guiding the formation of long myo-
tubes with length about 400  µm. They were fabricated using 
poly(lactic-co-glycolic acid) (PLGA) as short length ribbons with 
ultrathin thickness.[38] In contrast with the direct injection of 
cells, ultrathin ribbons could mechanically support the C2C12 
cells precultured on their surface. To evaluate the effect of the 
nozzle size on the injectability of ribbons and the viability of 
the pre-loaded cells, various needle gauges were used. The 
cell viability was evaluated by aspirating and injecting the cells 
through the various needles. We showed that the viability and 
functionality of the cells adhered on the ribbons after injection 
was preserved (Figure 3).[38]
Using microfluidic techniques, we also microfabricated 
fibers with a microgrooved surface to generate an aligned 
muscle micro-tissue on 1D fibers.[39] The microfluidic spinning 
approach was used to fabricate gelatin methacryloyl (GelMA)-
based fibers with well-defined micropatterns which could be 
combined in a study of topographical cues and biochemical 
stimulation using recombinant agrin. Microstructured fibers, 
in comparison with flat and smooth fibers, showed enhanced 
alignment of C2C12 cells and myotube formation after differ-
entiation. The myogenic behavior of the cells on these fibers 
was assessed based on myotube length, aspect ratio, and 
mRNA expression of myogenic genes, where micropatterned 
fibers showed enhanced formation of differentiated myotubes. 
Furthermore, we studied the effect of agrin treatment during 
the differentiation process and found it significantly enhanced 
the expression of acetylcholine receptor (AChR) and dystro-
phin. More AChR clusters and myotubes were formed, which 
indicated that the synergistic effect of topographical cues and 
agrin treatment could enhance the functionality of the created 
muscle tissue. Moreover, the differentiated myotubes showed 
synchronized contractility under electrical stimulation in high 
numbers (Figure 4).[39]
Mirani et  al.[40] used a similar approach to demonstrate the 
fabrication and application of hydrogel-based fibers with micro-
scale morphological features (grooved, solid, and hollow) for 
smart drug delivery, wearable or implantable medical devices, 
and soft robotics applications. The C2C12 myoblasts cultured 
on the grooved fibers showed improved alignment as well as 
enhanced and controlled myogenic differentiation. The mor-
phology of the cells varied depending on the groove size of 
fibers (Figure 5A), as well as the specific material composition 
(Figure 5B); cells on smooth fibers showed random orientation, 
while on the grooved fibers they demonstrated an increase in 
directional alignment toward the direction of the grooves, pos-
sibly due to decreased groove sizes (Figure 5A).[40]
Fallahi et  al.[41] also fabricated multi-component composite 
fibers, made of a polymer core and coated with a GelMA/
alginate hydrogel. Fibers were later assembled through textile 
processes in various 2D and 3D structures to tailor tissue-level 
properties and guide the direction of cellular growth within the 
3D microenvironment. The core fibers were made of polydisox-
anone (PDMS), polyglycolic acid, collagen, and cotton, and were 
coated by a cell-encapsulated layer of GelMA/alginate hydrogel 
blend. Furthermore, as conductive materials such as graphene 
or carbon nanotubes can affect the function and maturation 
Figure 2. Advances in SMT engineering—from traditional to functional approaches. Traditional tissue engineering approach is the combination of the 
components such as biomaterials, cells, and growth factors. However, these three main components need to be combined with regulators or external 
stimuli allowing for more biomimetic characteristic in engineered SMT. Adapted with permission.[27] Copyright 2018, Frontiers.
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of electro-physiologically responsive tissues such as cardiac, 
skeletal muscles and neural tissues, they fabricated electri-
cally conductive fibers using reduced graphene oxide (rGO). 
C2C12 mouse myoblasts cells encapsulated in both coated 
and non-coated fibers showed enhanced adhesion, prolifera-
tion, and maturation in the direction of the fibers. However, 
C2C12 cells encapsulated in rGO-coated fibers seemed to 
be more elongated and confluent than their non-coated 
counterparts.[41]
1D models, such as the previously-discussed single fibers, 
can only carry the cells on their surface. To imitate the 3D envi-
ronment of the muscle tissue, and to grow an effective and 
mature tissue model, the 1D building blocks/1D models must 
be assembled using a bottom-up approach through a variety of 
processing techniques. For example, Yang et al.[56] reported on 
the fabrication of a poly(ε-caprolactone) (PCL)-based scaffold 
using 3D printing. In this case, uniaxially aligned surface topog-
raphy provided a 2D culture surface platform, created by the 
stretching of a 3D-printed scaffold. The aligned myotubes pro-
duced on the stretched 3D printed PCL fibers were compared 
to those formed on unstretched PCL struts. Not surprisingly, 
the stretched PCL fibers showed greater myoblast alignment 
and more elongated morphology. After 7 and 14 days of culture, 
the myotube formation on all samples was determined using 
myosin staining. The level of mRNA expression of various 
muscle-specific genes was analyzed and demonstrated that 
Myf5, MyoD, Myogenin, and MHC were significantly increased 
in stretched-PCL compared to those in unstretched-PCL struts. 
The expression of Myf5 and MyoD before myogenic differentia-
tion are relatively higher, as Myf5 is associated with myoblast 
positioning, and MyoD is responsible for muscle cell regen-
eration.[57,58] In contrast, Myogenin and MyHC are involved 
in the differentiation of myoblasts into myotubes; therefore, 
their expression was significantly greater in cells grown on the 
stretched PCL.[56]
Liu et  al.[44] demonstrated the application of collagen fibers 
for the culture of myoblasts as 2D collagen fiber networks. 
These cell-laden fibers were embedded into non-cell-adherent 
agarose hydrogels, which then displayed greater alignment 
and increased differentiation of the myoblasts.[44] The 2D colla-
genous network was made by layering the fibers on a collector, 
thereby forming organized meshes with controlled alignment. 
By varying the number of assembled layers, or by embedding 
the fibers in a hydrogel, the system could be upgraded to a 3D 
network to grow the skeletal muscle cells (Figure  6A). Over 
3 days of culture, C2C12 cells adhered and grew along the 
fibers, forming fascicle-like structures (Figure  6B). Myotube-
like structures were formed on fibers which were embedded in 
hydrogels containing collagen rather than pure agarose hydro-
gels (Figure  6C). Immunostaining confirmed the expression 
of key markers for differentiation such as myosin heavy chain, 
parvalbumin (Ca2+-binding protein in fast-contracting skeletal 
muscle fibers), and the nitric oxide synthase isoform (NOS-1) 
in most of the aligned skeletal muscle cells growing on collagen 
fibers (Figure 6C–F).
Topographical cues can also be introduced into SMT engi-
neering systems via surface patterning and applied coatings. 
Micropatterning has been used for the generation of simple 
or complicated motifs (e.g., grooves and ridges, pillars, and 
wells) and microstructures on various substrates with flat or 
curved features and can be applied by photolithography. It 
enables us to direct specific cell behaviors, such as the spatial 
arrangement and differentiation of muscle myoblasts.[31a,45] 
Denes et al.[46] applied this method to fabricate micropatterned 
Figure 3. A) Field emission-scanning electron microscopy image of C2C12 cells adhered on a ribbon after 2 days of culture (scale bar: 10 µm). B) Cell 
viability of skeletal muscle cells cultured on PLGA ribbons after 2 days of culture using live/dead staining (scale bar: 20 µm). C) Myotube formation on 
freestanding ribbons (scale bar: 50 µm) and exhibiting sharp A-bands (enlargement (scale bar: 5 µm)). Adapted with permission.[38] Copyright 2017, 
American Chemical Society.
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and unpatterned gelatin hydrogels in order to study the align-
ment and differentiation of C2C12 myoblasts.[46] The formation 
of aligned sarcomeres and myofilament protein concentra-
tion on C2C12 myotubes, grown in 10 µm-wide microgrooves 
imprinted in a gelatin hydrogel, was characterized. Moreover, 
the sarcomeric structures formed by the aligned cells, in com-
parison to the cells grown on the unpatterned surface, showed 
an increase in contractile protein content. A higher expression 
of genes related to the development of contractile proteins and 
in vivo muscle maturation has been detected in those cells 
grown on patterned structures (Figure 7).[46]
Similar to the 1D case, the micropatterned films or cell 
sheets, as a 2D culture model, cannot represent the true 3D 
structure of native muscle tissue; therefore, to create more 
flexibility and higher freedom for cells to grow in a 3D envi-
ronment, the cell sheets can be stacked and assembled as a 
multilayered constructs. This approach was investigated by 
Fujie et al.[47] by creating nanoribbon-sheets using microfabrica-
tion and spin coating from PLGA and stacking them together, 
with gaps between the single strips. They showed two or more 
of these cell-laden structures could be placed on top of each 
other with anisotropic (orthogonal) and isotropic (parallel) ori-
entations, better resembling the hierarchical structure of skel-
etal muscle tissue. They found that this method significantly 
facilitated the alignment of C2C12 cells into bilayer cell sheets, 
and improved the expression of muscle related genes such as 
Figure 4. A–F) myotubes formed on micropatterned and smooth GelMA fibers treated with and without agrin showed various length and aspect ratios. 
Immunostaining was performed using mouse antimyosin (MY-32) antibody (scale bars: 50 µm). Quantification analysis of G) alignment, H) length, 
and the I) aspect ratio of myotubes after 7 days of differentiation. Reproduced with permission.[39] Copyright 2018, John Wiley and Sons.
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Myogenin, Mrf4, MHC IIa, MHC IId (x); this method also led 
to spontaneous contractions without stimulation.[47]
3.2. 3D Engineered Muscle Tissue
Most studies on skeletal muscle have used 2D surface struc-
tures, as mentioned above, patterned in the micro-/nanoscales 
with various sizes and shapes inducing the alignment of myo-
blasts, towards the formation of myotubes. However, due to the 
lack of 3D structure they cannot be successfully transferred to 
the clinic. Therefore, various 3D culture systems with greater 
similarity to the 3D environment of native skeletal muscles 
are introduced and evaluated, further increasing the com-
plexity of the culture system. Herein, we will shortly review 
important recent work in order to introduce the potential of 
this substrate to develop mature, functional muscle micro-tis-
sues. For instance, aligned fibrous scaffolds were extensively 
used in recent years to take the field into 3D space.[48] Aligned 
fibrous scaffolds, due to their anisotropic structure, are one 
of the potential substrates that are highly successful, due to 
their resemblance of the anisotropic ECM of skeletal muscle. 
They can also be fabricated using various efficient processing 
techniques, such as electrospinning.[49] Several studies have 
shown that aligned fibers significantly improved the orientation 
of muscle cells and their myogenic response, while also pro-
moting the up-regulation of the genes typical for muscle tissue 
development.[48b,50]
Narayanan et al. showed the diameter of parallel electrospun 
PLGA fibers are also effective for the elongation of muscle cells. 
Aligned fibers, with fiber diameters ranging from 335 ± 154 nm 
to 3013 ± 531  nm, were characterized for their interactions 
with myoblasts. During in vitro culture, larger fiber diameters 
showed enhanced alignment and further facilitated the differ-
entiation of the cells, via the phosphorylation of the p38 MAPK 
chemical pathway. Furthermore, the expression of important 
MRFs, such as Myogenin and myosin heavy chain, were upreg-
ulated. In vivo studies also revealed that in dystrophin-deficient 
mdx mouse model, optimized fibrous scaffolds could support 
the formation of dystrophin-positive myofibers network in tibi-
alis anterior muscles.[50]
After ensuring the positive effects of aligned electrospun 
fibers, consisting of PCL and decellularized-ECM (D-ECM), 
on the development of primary satellite cells in vitro, Patel 
et  al. investigated the treatment of VML in murine models 
by implanting these fibers.[51] Their previous in vivo study 
using D-ECM fibers showed poor mechanical stability and 
quick degradation; therefore, in this study they produced the 
PCL/D-ECM blend, which effectively improved the anti-inflam-
matory activities and the myofiber formation in vivo. The 
myogenic protein expression of MyoD and myogenin, as well 
as the production of myokines, were all improved using the 
aligned blend of PCL/D-ECM fibers. However, there were no 
effects on the mass of myofibers grown in the VML injury 
model and force production apparent.[51–52]
Application of conductive fibrous scaffolds have also been 
used to improve the myogenic capabilities of muscle cells. We 
demonstrated that composite electrospun gelatin-polyaniline 
(PANI) nanofibers doped with camphorsulfonic acid (CSA) 
could effectively support the culture of C2C12 myoblasts.[53] We 
observed that myotube formation on composite gelatin-PANI 
nanofibers was improved when compared to non-conductive 
Figure 5. A) Alignment of the C2C12 myoblasts on smooth and microgrooved fibers with different groove sizes (50 to 150 µm). B) Multicomponent 
fibers fabricated from GelMA and Alginate are shown in length and cross section. As a core shell fibers, GelMA 10% was used as a core and Algiate 2% 
was used as a shell which could be removed after the crosslinking of GelMA. Adapted with permission.[40] Copyright 2020, American Chemical Society.
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gelatin nanofibers; these benefits were in addition to their 
ability to concomitantly promote myotube maturation. The 
maturation of myotubes was further studied by analyzing the 
intracellular organization and formation of sarcomeric actin 
units, as well as through characterization of the co-localiza-
tion of the dihydropyridine receptor (DHPR) and ryanodine 
receptor (RyR), calcium transients, myotube contractibility and 
the expression of genes correlated to the excitation-contraction 
(E-C) coupling apparatus, which were all significantly enhanced. 
A fibrous system comprised of electrically conductive fibers 
with diameters in the range of 300 nm showed effective combi-
nation of topography and electrical conductivity promoting the 
maturation of muscle tissue (Figure 8).[53]
Graphene-containing fibers also showed similar improve-
ments of myoblast differentiation, demonstrating the syn-
ergistic effect of the substrate’s micro-/nanostructure and 
its electro-responsive properties. Interestingly, Patel et  al.[54] 
induced the differentiation of muscle cells on graphene com-
posite PCL fibers in the complete absence of differentia-
tion media. The resulting graphene-PCL scaffolds presented 
improved mechanical and physical properties, which could be 
tuned by varying the graphene concentrations. It supported the 
adhesion and proliferation of C2C12 mouse myoblasts as well 
as the differentiation of those cells in normal growth media, 
suggesting the cell-instructive potential of the scaffolds. Patel 
et al.[55] further showed the effect of growing carbon nanotube 
(CNT) carpets on carbon-based scaffolds, composed of inter-
connected microporous carbon foams and aligned carbon fiber 
mats, to study the multiscale hierarchy architecture with con-
trolled physico-chemical properties. Controlled nano-roughness 
and wettability facilitated the myoblasts’ ability to adhere, grow 
and differentiate on the surface of the CNT carpet. Microporous 
foam architecture, in this case, failed to promote their fusion 
into multinucleated myotubes, which can be due to the absence 
of the anisotropic orientation within the foam structure. Never-
theless, the aligned fibrous architecture was still able to stimu-
late the successful formation of multinucleated myotubes.[55]
It must be noted that while carbon-based nanomaterials, 
such as graphene, graphene oxide, reduced graphene oxide and 
carbon nanotubes, may enhance desired muscle cell functions 
in vitro, their safety requires careful assessment. A significant 
number of studies have been performed to study the short- and 
Figure 6. Incorporation of collagenous networks in 3D hydrogel scaffolds to support the cell alignment and myogenesis. A) Incorporation of dry fabrics 
in agarose. B) Epifluorescence images showing the distribution of actin filaments in constructs with and without fabrics to promote the alignment of 
encapsulated C2C12 cells. C) Confocal microscopy images showing details of aligned fascicle-like structures. C2C12 cells adhered to collagen networks 
within the hydrogels display differentiation markers such as myosin heavy chain, parvalbumin and NOS-I. All scale bars, 50 µm. D) Western blots con-
firmed the expression of myosin heavy chain, parvalbumin for cells grown in 2D in comparison with cells grown in 3D with (3D (+)) and without (3D 
(−)) fabrics. Expression of myosin heavy chain E) and parvalbumin F) relative to GAPDH measured by quantitative polymerase chain reaction (qPCR). 
Adapted with permission.[44] Copyright 2017, Springer Nature.
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long-term in vivo cyto- and bio-compatibility, as well as carci-
nogenic potential of graphene-based nanomaterials synthe-
sized with a variety of methods and starting materials.[56] Fadeel 
et  al.[57] in an extensive recent review article summarized the 
safety assessment of these materials with respect to their poten-
tial effects on human health and the environment.
Hydrogels have had great success in similar tissue engi-
neering applications due to their inherent tunable physical and 
chemical properties, as well as their hydrophilicity, high water 
content and structural allowance for the diffusion of oxygen, 
nutrients, and bioactive molecules. Their mechanical proper-
ties, such as elastic modulus, can be tuned using various phys-
ical and chemical crosslinking techniques to be more similar to 
those of native skeletal muscle, to support the mature skeletal 
muscle development.[58]
Hydrogels can be derived from a wide variety of natural, 
synthetic, or hybrid materials.[58–59] Pollot et al.[60] has screened 
different types of hydrogels for to determine their suitability 
in SMT engineering. They investigated the tensile mechanical 
properties of collagen I, agarose, alginate, fibrin, and collagen-
chitosan, and investigated their ability to grow skeletal muscle 
in vitro during 14 days of myoblast culture. In the listed mate-
rials, collagen, fibrin, and collagen-chitosan hydrogels, with 
average elastic moduli ranging from 2.7 to 3.7 MPa, all demon-
strated better myogenic results. However, neither the very stiff 
agarose hydrogel (elastic modulus of 87.3  ±  32.6 MPa) nor the 
very brittle alginate hydrogel, which was very poor in handling, 
promoted myogenesis. The researchers successfully tested the 
collagen, fibrin, and collagen-chitosan hydrogels in vitro, and 
found that the primary rat satellite cells cultured on them after 
stretching could get activated and elongated without failing. 
The behavior of satellite cells, characterized by their genetic 
RNA expression of MHC, MyoD, and Myogenin, indicated the 
differentiation and maturation of satellite into contractile units. 
Figure 7. Immunofluorescence images showing sarcomere formation after post differentiation of the C2C12 cells cultured on A) Collagen coated glass 
B) Unpatterned gelatin hydrogels C–F) Patterned gelatin hydrogels. G) Greater formation of sarcomeres on patterned surface in comparison with 
others: H) Sarcomere length I) Percentage of sarcomere forming myotubes. Adapted with permission.[46] Copyright 2019, Springer Nature.
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MyoD expression had decreased during the 14 days of culture, 
while the expression of Myogenin had peaked on day 7 before 
decreasing for all five hydrogel types. In the end, only fibrin 
had significantly greater MHC expression on days 7 and 14 of 
culture.[60]
Gholobova et al.[61] showed fabrication of bio-artificial tissue 
constructs into organoids of skeletal muscle. They were made 
of a muscle bundle consisting of aligned myofibers, able to 
contract upon electrical and/or mechanical stimulation. Various 
types of muscle cells (C2C12 mouse myoblasts, human 
myoblasts or human mixed muscle cells isolated from muscle 
biopsies) were mixed with a natural, human fibrin hydrogel in 
a silicone mold, which contained two anchor points. Within a 
week of culture, the cell-gel mix contracted to form multinucle-
ated myotubes aligned between the anchors. The aim was to 
use this system as a model for intramuscular drug injection, in 
order to decrease the need of in vivo animal studies.[61]
Unfortunately, the hydrogel itself is not able to provide any 
topographical cues to the encapsulated cells to promote the 
formation of mature and functional skeletal muscle tissue. To 
form aligned myofibers within the hydrogels, either external 
stretching is required or a variety of processing techniques are 
necessary; additionally, a second component to the structure 
can be used as a topographical cue to modify the structure and 
properties of the hydrogels.[59,62] For example, Kim et al.[63] pub-
lished a report on an innovative hydrogel which consisted of 
uniaxially surface-patterned cylindrical struts. Collagen matrix, 
a main component of the muscle ECM in the form of micropat-
terned struts, and PCL were used to generate this 3D hydrogel 
and induce anisotropic cell alignment. The fibrillated poly(vinyl 
alcohol) (PVA), here used as a sacrificial material, was either 
mixed with PCL (PVA/PCL solution (PVA:PCL = 3:7)) or col-
lagen (20  wt% PVA and 4  wt% collagen) to create filaments 
for the 3D printing of micropatterned PCL and collagen struts 
Figure 8. Myotube formation after 6 days of differentiation shown by fluorescence microscopy on A–D) Aligned electrospun gelatin nanofibers with 
and without CSA and PANI. E) Percentage of myotubes which showed A bands in their structure and F) Phase-contrast image showing the A bands in 
myotubes at day 4 of differentiation. Adapted with permission.[53] Copyright 2017, American Chemical Society.
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with an aligned/anisotropic surface. After the printing, PVA 
was leached out and eventually the PCL or collagen struts with 
specifically aligned/anisotropic surface patterns were obtained. 
Furthermore, struts were coated with 0.5 wt% collagen and 
immersed in 1-ethyl-3-(3-dimethylamino propyl) carbodiimide 
(EDC) for crosslinking. On the micropatterned collagen sur-
faces, myoblasts showed full alignment as well as a signifi-
cantly higher level of myotube formation, in comparison to 
the collagen structures that were not treated with the micropat-
terning process.[63–64] This group also used collagen as a bioink, 
combined with a 3D fibrous bundle structure fabricated by an 
electrohydrodynamic (EHD) process. The fabricated scaffold is 
composed of 3D microfibrous bundles laden with myoblasts 
encapsulated in a collagen bioink. The fibers after stretching 
became uniaxially aligned to obtain a fully aligned 3D structure. 
Encapsulated muscle cells were later released from the col-
lagen bioink, aligned on struts and differentiated to myotubes. 
They showed generation of a well-organized muscle tissue, by 
applying the synergistic combination of the aligned topological 
cues and high biocompatibility of collagen to enhance the rela-
tive expression of myogenic genes (Myf5, Myh2, MyoD, and 
Myogenin) (Figure 9).[65]
Other than hydrogels reinforced with fibers, or fibers which 
are modified by a hydrogel coating, various types of cell-laden 
fiber structures are also introduced as a 3D model to develop 
engineered SMT. The morphology and fabrication techniques 
that apply shear forces during the fiber formation can align the 
cells and provide a 3D environment for the cells to thrive. In a 
recent study, Urciuolo et  al.[66] demonstrated the formation of 
a 3D structure from primary myoblasts, or myoblasts derived 
from embryonic stem cells, as an in vitro model of human skel-
etal muscle with a fascicle-like morphology. This construct has 
the structure of a single fiber, and is formed within laminin-
coated micrometric channels constructed inside a 3D hydrogel. 
The stiffness of the hydrogel was adjusted to that of native 
skeletal muscle, in order to successfully promote myogenesis. 
Primary myoblasts cultured in this 3D culture model were 
able to undergo differentiation and maturation to form myo-
tubes, characterized by the expression and localization of key 
components of the sarcomere and sarcolemma. This approach 
supported the formation of human myobundles of ≈10 mm in 
length and ≈120  µm in diameter. Critically, it showed sponta-
neous contraction after 7 days of culture. In comparison to the 
2D culture of primary cells, transcriptome analyses showed 
higher similarity of the developed system in this work and nat-
ural muscle tissue. In addition, this culture model promoted 
the differentiation of myoblasts derived from embryonic stem 
cells. (Figure 10).[66]
Similarly, Chen et  al.[67] showed fabrication of cell-laden 
fibers similar to skeletal myofibers made of photocrosslink-
able hydrogels tens of centimeters long. The mechanical 
properties of the fabricated fibers could be tuned by modu-
lating the exposure time and the concentration of hydrogel. 
Additionally, external stretching provided an axis of align-
ment for the development of a more mature and functional 
tissue. Afterwards, C2C12 cells were well spread, elongated, 
and aligned themselves in the direction of uniaxial stretching 
(Figure 11)[67]
Figure 9. Schematic and microscopy images of cell laden construct. R-scaffold refer to random, A-Scaffold to aligned A), and C-Scaffold refer to 
collagen-coated C) scaffolds. Adapted with permission.[65] Copyright 2018, American Chemical Society.
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Additive manufacturing and 3D bioprinting techniques 
have also improved the precise fabrication of muscle tissue 
using a bottom-up tissue engineering approach. Biofabrication 
of a 3D construct more representative of the native structure 
was achieved via the fabrication of multi-layer structures. Yeo 
et  al.,[68] for example, investigated the effect of electrospun 
Figure 10. A) Schematic showing formation of cell-laden microfibers to form human myobundles. Human primary or embryonic stem cells (ES)-derived 
myoblasts were encapsulated into the micro-channels within the 2D hydrogel scaffold which were differentiated in myotubes forming 3D myobundle 
supported by the surrounding hydrogel. B) Immunofluorescence analysis for desmin (green) and dystrophin (red), for MHC (green) and for MHC 
and myogenin (red). Nuclei were stained with HOECHST (blue) in hESC cultured inside the 3D micrometric channels. Adapted with permission.[66] 
Copyright 2020, PLOS.
Figure 11. A) Schematic showing the fabrication of cell encapsulated microfibers, the fixation and mechanical stretching of the cell laden fibers. Applied 
uniaxial stretching, promoted the alignment, elongation and differentiation of the C2C12 cells. B) Bright field image of the cell-laden fibers (scale bar 
500 µm). C) Image of fixed and stretched microfiber under various strain ratios, D) myotubes formed within the microfibers in GelMA hydrogel, E) the 
diameter variation of the microfiber after stretching under various strain ratio. Adapted with permission.[67] Copyright 2020, American Chemical Society.
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PCL micro/nanofibers on the development of skeletal muscle 
cells. These cells were printed in an alginate/PEO hydrogel 
reinforced by PCL struts, in order to obtain a higher 3D struc-
ture. The researchers found that the cells aligned according to 
the direction of the aligned electrospun fibers. Compared to 
a random fiber mat as well as an example without any micro-
fibers at all, the cells grown on the aligned fiber scaffolds 
showed a higher expression of factors relevant for muscle 
development.[68] Other materials explored for mechanically sup-
porting the biofabricates are PLGA[69] or poly (ethylene glycol) 
diacrylate (PEGDA).[70] These materials supported the shape 
fidelity of the printed constructs during cell culture.
Zhang et al.[71] also showed application of melt electrowriting 
(MEW) technique in fabrication of a hierarchically organized, 
anisotropic and conductive scaffold with microscale grooves 
aligned on the top of unidirectionally-oriented nanofibrous 
mesh. These microfeatures supported the contact guidance and 
orientation of muscle progenitors, promoting the formation 
of anisotropic and mature tissue. After 7 days of culture, the 
H9c2 myoblasts produced an increased myogenic response due 
to the combination of nanoscale and microscale anisotropic 
surface topography in the fabricated scaffold. The differentiated 
myotubes formed on parallel patterned scaffold were longer 
than 600  µm, with higher expression of MHC and matura-
tion index (2.4-fold MHC surface coverage, 1.6-fold maturation 
index).
The issue of recreating the 3D environment for muscle 
cells which is key to the growth and development of func-
tional muscle tissue can also be tackled from a different 
angle. Naik et  al. [72] reported application of decellularized 
muscle tissue instead of processed polymers to mimic the 
hierarchical structures found in the native muscle tissue. The 
native skeletal muscle tissue derived from human tissue was 
decellularized and the remaining 3D structures containing 
collagen, laminin and fibronectin were examined for their 
biocompatibility after the chemical processing of the tissue. 
An in vitro study over 7 days with fibroblast cells confirmed 
the biocompatibility of the scaffolds. To examine the effects 
of the chemical removal of the cells on the mechanical prop-
erties of the native extracellular matrix Renya et  al.[73] con-
ducted tensile tests with decellularized scaffolds obtained 
from pigs. They reported no significant differences between 
the native and the processed tissue. An investigation of the 
intrinsic structure of decellularized scaffolds acquired from 
pigs was conducted by Wassenaar et  al.[74] Analyzing the 
scaffolds with SEM revealed the natural honeycomb struc-
ture from the remaining connective tissue.[74] The implanta-
tion of such scaffolds has proven to be beneficial for tissue 
regeneration.[75]
To further improve the scaffolds-cell-interaction Lee et al.[76] 
coated a D-ECM with an insulin growth factor (IGF) after the 
decellularization process. The additional growth factor sup-
ported the cell viability and the expression of a higher amount 
of myosin heavy chains compared to a D-ECM in comparison 
with collagen as control and without any additional factors after 
7 days of culture. These findings could be confirmed in an in 
vivo study over 1 and 2 months in rabbits with a tibialis ante-
rior muscle defect. The implanted grafts resulted in a higher 
amount of myofibers when coated with IGF.[76]
In conclusion, the decellularized tissue provides the neces-
sary structures with the corresponding mechanical properties 
as well as the natural composition of the components on which 
the cells adhere. The positive properties of the natural scaffolds 
might give the impression that further research of synthetic 
scaffolds made from materials other than natural derived poly-
mers is unnecessary. But there are several limiting factors that 
make other methods necessary. Due to the batch to batch vari-
ation of natural tissues a standardization of scaffolds derived 
from such tissue is difficult. The morphology of the obtained 
scaffolds cannot be adjusted to the patient’s needs and a rejec-
tion of the transplanted scaffolds due to immunogenicity 
cannot be excluded. Therefore, the investigation of the other 
methods described in this review is of great importance.
3.3. 4D Engineered Muscle Tissue
Taking SMT engineering one-step further, time is added as 
a parameter for changing the morphology of the material 
on which the muscle cells are grown. Therefore, the concept 
of time is integrated within the 3D structure as the fourth 
dimension to introduce the next-generation of scaffolding to 
SMT engineering. 4D biofabrication techniques are used to 
fabricate dynamic and complex 3D architectures with specific 
geometry out of stimuli-responsive materials that can undergo 
shape transformation after exposure to various stimuli.[58b,77] 
We recently showed that 4D biofabrication can be used to 
increase the complexity of tissue-like constructs and precisely 
fabricate a complicated structure, such as skeletal muscle with 
tubular shape in a hierarchical manner.[78] Self-rolling bilayer 
PCL/ methacrylated alginate fibrous mats were used as sub-
strate to culture muscle cells. By triggering the swelling ratio 
of the bilayer, it could undergo a shape transformation and 
encapsulate myoblasts C2C12 cells and form a tubular shape. 
The overall thickness of the bilayer, the thickness of each layer, 
and the geometry of the mat are the key parameters in con-
trolling the direction of rolling and the diameter of the gener-
ated tubular shape. The myoblasts cells, after a total 14 days of 
culture and 7 days of differentiation, showed a highly aligned 
structure along the axis of the anisotropic PCL fibers and fur-
ther differentiated into contractile myotubes upon electrical 
stimulation and formed a skeletal muscle microtissue.[78] Simi-
larly, Vannozzi et  al.[79] reported fabrication of a fascicle-like 
implantable muscle construct from two stacked layers with dif-
ferential swelling degree, stiffness, and thickness. The bilayer 
made of two PEGDA hydrogel layers at different molecular 
weights could undergo a programmed self-folding and form 
a 3D tubular shape. In this construct, the inner side of the 
tubes could guide the muscle cell adhesion and their spatial 
alignment. This construct was tested further for both skeletal 
and cardiac muscle cells (human induced pluripotent stem 
cell-derived cardiomyocytes). High viability was measured for 
both types of cells and cardiac myocytes maintained their con-
tractile function over a course of 7 days.[79]
Miao’s group[80] created a 4D anisotropic skeletal muscle tissue 
using a staircase defect strategy. A staircase defect is an inevitable 
type of defect in fused deposition modeling (FDM) due to the 
nature of the layer-by-layer deposition of the material during the 
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3D printing and thus, as a result, the surface of the construct 
exhibits contour-like topography. Contour-like topography is com-
posed of aligned lines, and this group studied the effect of such 
an oriented structure on the formation of an anisotropic skeletal 
muscle tissue. The myogenic differentiation of bone marrow 
human mesenchymal stem cells under the influence of these 
topographical patterns showed that 3D printed PCL could 
regulate the behavior of cells toward SMT.[80] Combination of the 
surface coating techniques and shape memory polymers such 
as PCL supported the fabrication of 4D structures. It was shown 
that this biomimetic strategy supported the formation of highly 
organized functional SMT where higher myogenic genes expres-
sion such as myoblast differentiation protein-1, desmin, and 
MHC-II after 14 days of culture was detected.[80]
The techniques that utilize time during the transformation 
and formation of mature and functional tissue from printed, 
cell-laden constructs are also frequently regarded as 4D bio-
printing. These potential interventions, unfortunately, have not 
been extensively researched for their applications in skeletal 
muscle tissue engineering.
For more serious injuries, the implantation of fully devel-
oped muscle tissue is necessary to completely restore the func-
tion of the tissue. Merely growing muscle cells on a scaffold 
is not enough to induce myotube formation with a mature 
intracellular structure capable of generating significantly higher 
forces. Therefore, in addition to the previously-discussed bio-
materials, various external stimuli can be deployed to improve 
the development of the myoblasts; several important studies 
involving these external stimuli are extensively reviewed in 
the following sections of this review paper. The incorporation 
of dynamic culture systems into existing classical SMT engi-
neering approaches has great potential for the improvement of 
tissue maturation.
4. External Stimulators
A robust background in muscle physiology is key to under-
standing how skeletal muscle tissue responds to various 
external stimuli. The sensitivity of muscle maturity to these 
stimuli is often attributed to the myofibers’ capacity for adapta-
tion, where physical forces can encourage the regeneration of 
current muscle structures. The application of external cues can 
not only activate the gene and protein production, but also aug-
ment the accelerated growth, leading to a more rapid develop-
ment of the tissue.[81]
Muscle cells proliferate more efficiently when biomaterials 
support their self-regenerative abilities and guide them through 
different biological pathways .[82] However, such static systems 
are not delivering the right amount of nutrients and growth 
factors in order to accelerate the regeneration process. Conse-
quently, pre alignment of the cells prior to their differentiation 
is key, as it promotes appropriate differentiation into func-
tional myofibers, as the various approaches to align the cells 
demonstrated in the previous section.[82] Skeletal muscle has 
an inherent highly adaptive capacity; however, when it is not 
properly trained, wasting and weakness can hinder potential 
recovery after treatment.[83] While this is a problem for muscles 
that have not been properly stimulated, the main advantage of 
muscle is that the benefits of training, such as increased resist-
ance, can be induced even after long periods of non-stimula-
tion.[83] Figure 12 summarizes different types of stimuli which 
have been used to restore the loss of normal functionality of 
muscle tissue. In this section, the effect and role of various 
external stimuli on skeletal muscle maturation and function-
ality will be reviewed.
4.1. Mechanical Stimulation
The importance of sustained loading for tissue development 
cannot be understated, especially in the beginning phases of 
skeletal muscle growth. During embryogenesis, besides deter-
mining myofilament organization, passive tensions play a role 
in the formation of myofilaments with specified weights, diam-
eters and lengths.[88] Furthermore, such stretching is effective 
in the preservation of healthy muscle throughout a person’s life; 
muscle stretching is particularly crucial for the developmental 
process of muscle, driven by the regulation of specific genes, 
the synthesis of new proteins, and the release of nitric oxide. 
The mechanical forces applied on muscle will be translated into 
chemical signals via mechanotransduction, which subsequently 
triggers the activation of satellite cells. This process increases 
the rate of protein synthesis, leading to increased hypertrophy 
and hyperplasia.[89] In short, the external mechanical sig-
nals will be measured by the cells through a variety of recep-
tors, integrins, and focal adhesions.[90] Thus, the cytoskeleton 
will start rearranging, transforming the deformations caused 
by these mechanical signals into important factors that may 
boost the tissue maturation.[91] Skeletal muscle is composed of 
thousands of fiber arrays that are tightly packed in the tissue. 
This array contributes to a more resistant structure, capable 
of undergoing repeated cycles of stretching and contraction 
without easily rupturing. These fiber arrays are themselves 
composed of thousands of differentiated myoblasts. The focal 
adhesions on the surface of these myotubes receive external 
mechanical cues, thereby stimulating a variety of the cellular 
membrane receptors, including integrins and cadherins. Sub-
sequently, the mechanical stimulation (MS) of these receptors 
activates particular signaling pathways throughout the cell 
body, boosting the rearrangement of the cytoskeleton according 
to the direction where stimuli was initially applied.[12–14b] The 
response of skeletal muscle cells also varies depending on in-
vivo or in-vitro tissue models, both in 2D and 3D.
Most of the myofibers in the body can express the whole 
gamut of available skeletal MHC isoforms; the specific protein 
composition of each fiber is driven by the stimuli that myofibers 
receive from the environment. As an example, researchers have 
reduced the stretch-induced strain typically experienced by a 
muscle, and saw the activation of certain intracellular regula-
tory pathways, which resulted in the MHC proteins converting 
from predominantly slow-type isoforms to primarily fast-type.[16] 
Through methods such as these, tissue engineers can directly 
impact the phenotypes of lab-grown myofibers to their benefit. 
Although there is a lot of published information about which 
strain profiles cause which isoform conversions, there are still 
significant gaps in our knowledge about the actual mechanisms 
behind many of these conversions.[8,13,14b,16,92]
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However, there has been various reports on the effect of 
mechanical stimulation as an external treatment of muscular 
injuries, triggering the self-regenerative capacity of the tissue 
in the process. Some of the first investigations conducted about 
effects of mechanical stimulation on skeletal muscle was in 1991 
by Goldspink et al.[91] who demonstrated the effect of 3 days of 
MS on soleus muscle hind limbs. These limbs had been sur-
gically extracted from rabbits by using a self-made external 
stimulator. Stimulation at 10 Hz addressed the rapid activation 
of MHC and fast sarcoplasmic reticulum Ca2+ ATPase proteins, 
repressing normal fast myosin heavy and light chain genes, 
slowing the contraction and relaxation characteristics. This 
leads to a faster mRNA expression, one which will increase the 
production of slow, type I, and fast oxidative IIA fibers that are 
critical for enhancing oxidative muscle capacity. Consequently, 
in comparison with non-stimulated muscle limbs (control), 
collagen concentrations were reduced, leading to thickened 
connective tissue within the muscle, showing sarcomeric res-
toration, which exhibited higher fatigue resistance and better 
functionality.
Powell et  al.[86] studied the effect of external mechanical stim-
ulation on human bioartificial muscles (HBAMs) fabricated 
from a collagen/Matrigel mixture, where muscle cells were kept 
in cultivation for up to 8 days prior to differentiation. Initially, 
HBAMs were placed on silicone rubber tissue molds supported 
by 2 mm stainless steel pins. A self-made mechanical cell stim-
ulator version 4 (MCS4) was used to stretch HBAMs for 4 days 
in intervals of ≈3.5 µm  every 10  min. One of the pins was in 
direct contact with the simulator to allow the transference of 
a unidirectional stretch amplitude of 25% (before rupture) and 
velocity up to 0.5 mm s−1. Sarcomeric analysis of static HBAMs 
showed formation of myofibers in only 2–10% of their cross-
sectional area with fiber diameters <10 µm  after 16 days of 
stimulation. In contrast to the static systems, the mechanically 
stimulated HBAMs showed a two- to three-fold difference after 
8 days of stimulation, where the fiber diameter increased by 
12% (6.4–7.1 µm) and myofiber area increased by 40%. In this 
study, they showed that periodic training is key for muscle fiber 
hypertrophy and growing more elastic muscle fibers in com-
parison with static controls. Moreover, mechanical conditioning 
allows rapid diffusion of nutrients towards the cells and faster 
remodeling of the tissue associated with repetitive mechanical 
loading.[86]
Recent advances of SMT engineering have enabled the devel-
opment of functional in vitro models. One of the principal stim-
ulators that is highly responsive to such effects is Interleukin 
6 (IL-6). Hicks et al.[92] stated that IL-6 induces proliferation of 
human dermal fibroblasts (NHDF)/C2C12 coculture systems, 
Figure 12. Types of external stimuli for skeletal muscle tissue engineering. A) Mechanical stimulation, B) electrical stimulation, C) magnetic stimula-
tion, D) chemical stimulation, and E) biological stimulation. A) Adapted with permission.[82] Copyright 2019, Nature Research. B) Adapted with permis-
sion.[83] Copyright 2017, Spandidos Publications Ltd. C) Adapted with permission.[84] Copyright 2015, Elsevier. D) Adapted with permission.[86] Copyright 
2002, Elsevier. E) Adapted with permission.[85] Copyright 2014, Frontiers.
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facilitating myoblast fusion and accelerating the overall tissue 
maturation. In their study, a Flexercell FX-4000 Tension Plus 
System was used to induce stretching on Bioflex culture 
plates throughout vacuum assisted regimes. Bioflex plates 
owned an elastomeric surface that allowed both cells (NHDF/
C2C12) to adhere, creating cellular monolayers that were tested 
under different stretching conditions: Cyclic short-duration 
stretches (CSDS) (10% strain, unloading rate of 33%/s, fre-
quency of 0.6 Hz, for 8 h), acyclic long-duration stretch (ALDS) 
(6% strain, loading rate of 3%/s, 60 s) and a combination of 
CSDS and ALDS (CSDS for 8 h, followed by 3 h resting and 
ALDS for 60 s). Non-stretched cells in differentiation medium 
were used as a control to characterize how myotube formation 
was impacted by the stretching device. To prepare the coculture 
system within the stretching device, fibroblasts were seeded in 
the Bioflex membranes, whilst myoblasts were seeded on non-
deformable glass slips facing downward the fibroblasts mon-
olayer with a 2 mm  distance between them. In the coculture 
system the strain was applied on fibroblasts only, however the 
diffusion of differentiation mediators secreted by fibroblasts 
could affect the unstrained myoblasts on coverslips. In cocul-
tures and after 96 h, ALDS following CSDS showed enhanced 
myogenesis and formation of higher number of myotubes by 
78%  versus CSDS alone. Cocultures systems subjected to a 
combination of both types of cyclic stretches (CDSD+ALDS) 
demonstrated an enhancement in the myotube formation in 
comparison to the monoculture system (myoblasts treated by 
0–100  ng mL−1 IL-6); similarly, fusion efficiency was signifi-
cantly higher in contrast to cells which had undergone either 
ALDS or CDSD conditions.[92]
As it has been discussed in previous sections, biomaterials 
are an attractive tool to use in the production of successful 3D 
cell-constructs, due to their beneficial properties for the promo-
tion of cell binding and their ability to serve as carrier for sev-
eral growth factors.[93] It has been shown that hydrogels, despite 
their relatively weak mechanics, can be easily stretched under 
static and cyclic conditions. The viscoelasticity of hydrogels 
offers a possibility to fabricate scalable and supportive materials 
for tissue fabrication. For instance, Bansai et al.[94] studied the 
effect of cyclic stretching (3% tensile strain at 1 Hz) applied on 
murine C2C12 cells encapsulated in core–shell hydrogel micro-
fibers. The C2C12 cells were encapsulated in the collagen gel as 
a core of alginate fibers, which were fabricated using a double-
coaxial laminar-flow microfluidic device; this device therefore 
resulted in a higher myotube length in comparison with typ-
ical static culture systems (C2C12 monolayer). They observed 
that applying a constant stimulation on microfibers using a 
custom-made cell culture device resulted in decreasing cell 
viability (Figure 13A). Contrary to this, cells in collagen hydro-
gels resulted in 70% of myoblasts successfully forming mature 
myotube structures. Cytoskeleton staining showed that encap-
sulated cells in the microfibers under cyclic stretching were 
significantly more aligned in comparison with the cultured 
monolayer as well as with the non-stretched cell-laden micro-
fibers (Figure 13B).[94]
Such results were congruent with Heher et al.[93] where static 
mechanical strain (10%) was applied through a self-built device 
(MagneTissue) to stimulate myoblasts embedded in fibrin gels 
for ≈10 days. They tested different fibrin concentrations, starting 
from the softest (10 mg mL−1) to the stiffest (40 mg mL−1) with 
stiffnesses in the range of 11.57–17.21  kPa. A concentration of 
20 mg mL−1 of fibrin was chosen as an optimal concentration for 
further MS. They detected the formation of a higher number of 
mature myotubes, characterized by length and diameter values 
in the range of 12–15 and 200–400 µm, respectively. After 3 days 
of mechanical strain (6 h), the alignment of the cells embedded 
in the fibrin gels was attributed to the transmission of the 
strain applied by MagneTissue. Moreover, RT-qPCR depicted 
a higher myogenic expression of MyoD and Myogenin after 
static strain. They also showed that mechanical stretching of the 
monolayer of cells (2D) did not produce similar results. Only 
partial alignment in the 2D system was detected, in comparison 
to the enhanced mRNA expression, sarcomeric production, and 
cellular alignment results obtained in 3D cultured systems.
Chen et  al.[67] also reported upon their work on 3D, fiber-
shaped cellular constructs, primarily used as a platform to 
grow functional and organized muscle tissue derived from the 
application of mechanical stimulation. A silicone tube-based 
coagulant bath was used to fabricate centimeters long cell-
laden microfibers, which then could be combined with photo-
crosslinkable hydrogels such as GelMA to form the microfibers 
with tissue-like microstructures. By varying the exposure time, 
the researchers were able to tune the mechanical proper-
ties of the hydrogel. The cell-laden fibers were later stretched 
using a pillar well array-based stretching device embedded in a 
culture system, to apply uniaxial stretching with various strain 
ratios in situ. C2C12 myoblasts showed improved spreading, 
elongation, and alignment under uniaxial stretching, and the 
Figure 13. A) Self-made cell device used for imposing cyclic stretching on C2C12 cells encapsulated in core–shell collagen gels. B) Fluorescent images 
of culture C2C12 cells on hydrogel microfibers before and after being cyclically stretching for 6 days at 1 Hz, with a 3% tensile strain. Adapted with 
permission.[94] Copyright 2019, MDPI.
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differentiation of the cells under uniaxial stretching was also 
improved. By increasing the strain ratio up to ≈35%, the con-
tractility of myofibers became more pronounced and reached a 
saturation level (Figures 11 and 14).[67]
It has been stated that stiffness of the scaffold material 
(hydrogels, electrospun meshes, etc.) is critical for mechanical 
stimulation. It is important that the materials used for encapsu-
lation of cells withstand several mechanical loadings in order to 
induce morphological changes in the cells. Therefore, it has been 
important to investigate the role of chemical and mechanical 
properties of scaffolds fabricated by different techniques in trans-
mission of the mechanical stimuli to cells and their response.[95]
For instance, the use of electrospun scaffolds of a DegraPol 
block co-polymer were also used by Candiani et  al.[96] as an 
alternative to hydrogels. They investigated the application of a 
self-made bioreactor, to study the role of static and cyclic stimu-
lation on microfibrous scaffolds (DegraPol strips with sizes of 
50 × 5 mm) for 13 days. After 4 days of culture, prior to starting 
dynamic cultivation, an additional batch of cells was added to 
samples aiming to improve efficiency of differentiating myo-
blasts. Samples inside the bioreactor were stimulated under 
cyclic stretching (frequency 0.5  Hz, amplitude 1  mm, com-
prising 30  sec rest and followed by 28  min rest). During ini-
tial stretching, no differences in terms of expression of MHC 
was seen between static and cyclic conditions; however, from 
day 7 in the static system, there was a reduction of 36% in 
expression of MHC in comparison to the dynamic stretching 
which showed an increase of 67%. Besides that, densitometric 
Figure 14. A) Fluorescent microscopy images showing the uniform distribution of the sarcomeres and Z-line striation in mature myotubes. The length 
of the sarcomere is measured by manually drawn white line in the right figure. White scale bar equals to 10 µm (left) and 5 µm (right). B) Confocal 
images of the myotubes under 25%, 35%, 45% strain showing a partial striated pattern. White scale bars equal to 25 µm. C) Correlation of the strain 
ratios (25%, 35%, 45%) and the sarcomere length of myotubes grown within microfibers. D) Contraction displacement of myotubes is shown as a 
waveform graph after electrical stimulation: 6 V cm−1, 2 ms, different frequency (the top); 1 Hz, 2 ms, different field electric field intensity (the bottom). 
Quantification of myotube contraction displacements under various parameters related to ES such as E) Frequency F) Electric field intensity and 
G) Strains. Adapted with permission.[67] Copyright 2020, American Chemical Society.
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analysis demonstrated that at day 10 there was a significant 
8-fold increase in the expression of MHC protein due to the 
mechanical effect produced by the cyclic stretching imposed 
within the bioreactor. Such a mechanical effect was also con-
firmed with MHC immunostaining, where stretched strips 
were assessed with an epifluorescence microscope, exhibiting 
denser fiber arrays within more defined myotube packs. In con-
clusion, in vitro mechanical stimulation of 3D culture models 
could effectively accelerate the maturation of engineered 
muscle constructs in comparison with 2D systems.[96]
4.2. Electrical Stimulation
Motor neurons (MNs) within skeletal muscle regulate cell 
membranes’ depolarization during fiber stimulation, leading 
to proper contraction response (force) that is dependent on 
the size and the healthy state of the muscle fibers. Unfortu-
nately, loss of force is one of the common issues coming from 
the fatigue of skeletal musculature, where the MNs’ frequency 
starts decreasing (20 to 10 Hz)  and as a response skeletal 
muscle shows a reduction in the tetanic ability (contraction).[97] 
External ES is one of the most often used techniques for nerve 
stimulation, in order to circumvent muscular fatigue. Since 
electrical stimulation (ES) is also crucial for the function of 
skeletal muscles, it is logical to study the effects of electrical 
stimulation, and the presence of the neural structures that pro-
vide that stimulation in vivo, which activate similar regulatory 
feedback systems in the myofibers. For example, during the 
first month of neonatal muscular development, scientists have 
discovered that the presence of an intact nerve is necessary for 
the proper growth and maturation of new fibers.[16] The mature 
musculature is innervated by neural structures in vivo which 
provide further stimuli for the differentiation of satellite cells 
and the conversion of MHC isoforms. Neuromuscular junc-
tions (NMJs), where neurons attach to skeletal muscle fibers, 
provide the appropriate environment to send and receive 
important neurotransmitters, such as acetylcholine.[98] Once 
an action potential is propagated into the skeletal muscle envi-
ronment via the NMJ, a series of ions such as Ca2+ flood from 
their respective stores to the intracellular environment, eventu-
ally leading to a contraction of the sarcomere.[99] They observed 
that applying electrical functional fields on C2C12 muscle mon-
olayers, can affect the fiber response to electrical stimulus by 
repeatedly stimulating the actin and myosin proteins inside of 
the myofibrils.[100] While this mechanism is dissimilar from the 
mechanotransduction pathways, the results indicate that both 
methods have some degree of authority over the MHC compo-
sition of the myofibers.[101] Moreover, declination of muscular 
efficiency is one of the principal issues produced by aging. 
Reduction of the myofiber size, denervation or even contracti-
bility problems are common factors produced by the muscle 
weakness. ES has been commonly used as a rehabilitation 
technique in order to circumvent aging diseases. For instance, 
Mosole et al.[102] studied the neuromuscular responses triggered 
by ES for 7 days using a self-made battery-powered stimulator 
(I: 128 ± 16 mA and V: 39 ± 14 V) on a few patients after placing 
rubber electrodes on the skin. Muscle biopsies from stimu-
lated patients showed a faster muscle restoration response. 
ES can reactivate the regulation of important markers such as 
Serca2, pCamKII that would increase the numbers of suitable 
myofibers in order to tackle muscle weakness and fatigue con-
ditions associated with aging-related pathologies.
Kaji et  al.[103] showed that a monolayer of cells which were 
electrically stimulated exhibited formation of internal structure 
and sarcomeric units. The excitation-contraction coupling in 
the stimulated cells showed higher reflux of Ca2+ in compar-
ison with non-stimulated cells indicative of higher maturation. 
They cultured the C2C12 cells as a confluent and differenti-
ated layer on an alumina porous membrane coated with a thin 
PDMS layer (0.1 mm) from the underside and an atelocollagen 
membrane (20 µm) on the upper side. In a self-made electrical 
stimulator, they placed two platinum (Pt) electrodes above and 
under the alumina membrane to focus the electrical pulses on 
the cells using amplitude: 4  mA, duration: 20  ms, frequency: 
1 Hz. Differentiated myotubes were grown on the atelocollagen 
membrane with muscle tissue-like stiffness. The contractile 
myotubes also showed higher glucose uptake after measuring 
the uptake of fluorescence-labeled glucose (2-NBDG) and 
detecting significantly higher GLUT-4 translocation.[103]
Furthermore, the effect of electrical stimulation on muscle cell 
maturation, cultured in vitro in 2D and 3D culture systems, was 
studied by Langelaan et  al.[104] They observed applied electrical 
fields on C2C12 muscle monolayers (2D culture system) leads 
to rapid consumption and reduction of nutrients within the 
medium. Expression of α-actinin and sarcomeric myosin showed 
no cross striation formation on 2D controls. Later, they have 
translated the results found in cell lines (C2C12) to a primary cell 
source, muscle progenitor cells (MPCs), which were encapsu-
lated in collagen type I/Matrigel hydrogel generating a 3D culture 
system. In contrast, in 3D system and using MPCs, fabricated 
bioartificial muscle models (mBAMs) after 3 days of ES (4 V cm−1, 
6 ms pulses at a frequency of 2 Hz) showed cross-striations and 
higher expression of mature MHC isoforms. Significantly higher 
numbers of aligned myotubes were formed and the expression of 
important muscle markers such as α-actinin, MLP, MYH8 and 
sarcomeric myosin was upregulated confirming the formation 
of sarcomeric units after 48 h of stimulation. This study could 
clearly confirm the synergy of external stimulation, 3D culture 
systems, and suitable cell sources such as MPCs in supporting 
muscle maturation, myogenesis and accelerating the sarcomere 
assembly towards higher contractility.[104]
Furthermore, 3D cell culture systems have been used in 
various studies for evaluation of electrical stimulation. For 
example, Davis et  al.[105] studied how direct electrical stimula-
tion led to fast oxygen consumption by human muscle cells. 
They seeded human myoblasts on a Matrigel/fibrin gel within 
a PDMS mold and studied mitochondrial respiratory function, 
before and after stimulation, using an Oxygraph-O2 respirom-
eter. After differentiation, the myobundles were moved to a 
self-made microphysiological flow chamber and electrically 
stimulated using carbon flat electrodes (40  V cm−1, twitch: 
1 Hz duration:10 ms and tetanic: 20 Hz, 1 s). Under this stimu-
lation, the myobundles’ respiration tends to increase; however, 
the Matrigel significantly affected the oxygen consumption 
in the contractile myobundles. Furthermore, they studied the 
oxygen transport in human skeletal muscle cells encapsulated 
in the gel with ES for 30 min., which showed a 20-fold increase 
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in the respiration of skeletal muscle cells when no matrix was 
provided.[105] Continuing studying the role of biomaterials in 
reducing the side-effects produced by applied electrical fields 
on human myoblasts, Khodabukus et al.[106] studied the forma-
tion of myobundles (iSKM) in Matrigel and the effect of inter-
mittent ES (1–10 Hz, 70 mA amplitude and 2 ms duration) on 
the rate of maturation of the myotubes. After differentiation, ES 
was continuously performed on a self-made PDMS chamber 
between week 1 and 2 of differentiation using the program 
LabVIEW. Immunostaining showed that the number of nuclei 
in simulated 3D myobundles was augmented 1.5 fold in com-
parison with non-stimulated control and non-stimulated 3D 
myobundles. Furthermore, there was a 1.8-fold increase in the 
myobundles’ cross sections. Additionally, Dystrophin/nuclei 
staining exhibited a higher sarcomeric organization due to 
the increase in the myotube length under the constant effect 
of electrical stimulation. Western blots confirmed the results 
by displaying higher expression of sarcomeric proteins such as 
dystrophin and MHC in comparison with 2D controls and non-
stimulated myobundles. After applying the constant tetanic 
contractions triggered by ES, fatigability of cells was studied 
by measuring the glycolytic metabolism. Higher expression of 
glucose transport proteins confirmed the reduced fatigue resist-
ance in comparison with non-stimulated myobundles.[106]
Another evaluation on mature muscle tissue involved 
measuring the release rate of myokines from skeletal muscle 
cells stimulated electrically using an external electrode 
system (Figure 15A). It was shown by Nagamine et  al.[107] that 
myokines, as specialized cytokines in charge of regulating 
levels of glucose within the body and remodeling responses in 
an injured muscle, increased under ES.[108] Encapsulated C2C12 
muscle cells in collagen and Matrigel were cultured around 
poly(3,4-ethylenedioxythiophene (PEDOT)/polyurethane (PU) 
wire films (3 µm  thickness) and stimulated with non-faradaic 
ES using charge and discharge currents (5  mA amplitude, 
10 ms duration, 50 µC charge). SEM images of cells around the 
wire showed an early alignment and no toxicity was detected 
after 3 days of culture (Figure  15B). After 7 days of differen-
tiation, myotubes displayed contractile behavior with twitch 
forces at low frequencies of 1 and 5 Hz and tetanic contraction 
at high frequencies of 10 and 20 Hz (Figure 15C). The lack of 
cell detachment not only proved that the faradaic contraction 
did not cause significant damage to the cells, but also enhanced 
their sarcomere maturation in comparison with conventional 
systems using external electrodes.
In conclusion, ES can trigger partial restoration of the normal 
contractility functions of muscle cells, but still lacks proper con-
trol over complete reformation and functionalization of muscle 
tissue. Contractility of the myotubes is highly affected by the stiff-
ness and mechanical properties of the scaffold used. However, 
ES still faces problems in the way stimuli are transmitted along 
the scaffolds and reach the cells, causing suppression of MHC 
expression, and reduction of myoblast differentiation.
4.3. Magnetic Stimulation
As an alternative to electrical stimulation on the actual muscle, 
which is traditionally done by stimulating the nerve trunk 
through the skin, magnetic fields have been proposed as they 
can be effective while being a less invasive approach.[109] It still 
can penetrate deep into the muscle and stimulate it by gener-
ating a depolarization of the muscle cell membranes, which is 
an important feature as this depolarization is critical to effec-
tively regulate the intensity of the contractile forces applied by 
the cells.[110] Originally, magnetic stimulation was proposed for 
the stimulation of the nervous system or for the treatment of 
urinary incontinence. However, few studies have confirmed its 
potential application for skeletal muscle regeneration due to the 
reduction in the twitch force generated by constant magnetic 
pulses.[111] Despite its great potential, the mechanism of how 
magnetic fields stimulate these cells, thereby triggering muscle 
restoration, has not been deeply studied in in vitro models, as 
the majority of the studies are focused on boosting rehabilita-
tion in mice and humans models. For instance, Stölting et al.[112] 
tested the effects of direct magnetic fields on a transverse injury 
generated in the quadriceps from C57 mice, using a Biocon 
2000 W. The thighs from the animals were placed in the coils 
of the magnetic stimulator and subjected to a 20 min session 
conducted for 10 min at 10 Hz and 10 min at 50 Hz. Non-stim-
ulated animals were considered as controls in order to char-
acterize the extent of the muscle restoration. Tissue removed 
Figure 15. ES stimulation approaching 3D muscle-like systems. A) internal and external electrode systems used for excitation of skeletal muscle bundles 
composed of a myobundle layer wrapped around a PEDOT/PU conductive wire film, B) SEM image of conductive wire and C) Displacement triggered 
by contraction response of myotubes around the wire against the duration of the applied electrical pulse. Adapted with permission.[107] Copyright 2018, 
Springer Nature
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from the quadriceps after 5 days of stimulation depicted a faster 
restoration of the injury, characterized by cross-sections of the 
regrown tissue in comparison with those of non-stimulated 
specimens. In this experiment, non-stimulated controls exhib-
ited atrophic muscles due to the lack of hypertrophy promoted 
by magnetic stimulation. Immunostaining of muscles depicted 
higher expression of MHC in comparison with controls, and 
western blots confirmed previous results showing a 3-fold 
increase in MyH1 in contrast with non-stimulated tissues. 
Moreover, magnetic fields showed the ability to improve the 
contraction of muscles, due to re-innervation effects produced 
by the stimulation. Under magnetic stimulation, 3-fold higher 
formations of NMJ were confirmed in the stimulated tissues 
in comparison with controls. This observation confirmed the 
effects of magnetic stimulation as a potential treatment for 
muscle injuries as well as on nerve regeneration during muscle 
failure.
Magnetic stimulation has also been implemented in SMT 
engineering to study its effects in in vitro models in 2D or 
3D cultured systems; however, one of the major drawbacks 
of applying direct magnetic fields on different types of cells is 
the possibility to generate abnormality in terms of cell growth 
(cancer) due to the rising magnitude of the magnetic field 
(1–10 T).[113] For instance, 2D culture of skeletal muscle (L6) 
cells was studied by Coletti et al.[114] using static magnetic fields 
(SMF). Initially, cells were cultivated for 1 day and differentiated 
for 4 days. SMF exposure started immediately after cell seeding 
and continued throughout the duration of the experiments. 
Magnetic stimulation (80 mT) was applied on the cell mono-
layer using a custom-made device, while a control system was 
cultured without stimulation for 5 days. Aligned and organized 
actin filaments were detected after Actin/nuclei staining in con-
trasts with non-stimulated controls, and a significant number 
of cells showed successful fusion and formation of myotubes 
(65% ± 3.6%). Mueller et al.[115] also studied the application and 
effect of a SMF ≈80 ± 5 mT on a coculture system of myoblasts/
mesenchymal stem cells. In this study, no difference in terms 
of the levels of Myf5 marker was detected.[115]
Strong SMFs are often discussed, as they have the potential 
to help guide myofilament orientation. Sakurai et  al.[116] used 
a magnetic gradient of 0–41.7 T m−1 with a flux density of 0–10 T 
on differentiated C2C12 myoblasts, in order to assess the 
minimum field necessary for guiding myotubes orientation 
during differentiation. As a result, after 6 days of differentia-
tion and magnetic stimulation, C2C12 cells showed a positive 
time-dependent proliferative response, with the myoblasts suc-
cessfully forming a closely packed and aligned structure. When 
a magnetic field is applied on biological materials, there is the 
production of a torque force (diamagnetic anisotropy), that is 
key for aligning the actin within differentiated myotubes, sub-
sequently increasing their length. These results suggested that 
the highest magnetic gradient (41.7 T m−1) and density (10 T) 
depicted significantly better myotube orientation in contrast 
with lowest tested densities (3 T), which provided only a mod-
erate flux and no production of diamagnetic anisotropy. Finally, 
differentiation and proliferation characteristics of both stimu-
lated and non-stimulated cells were studied by immunostaining 
of MHC. Results showed that even where there was a slight 
increase in the MHC content of stimulated cells in comparison 
with control, the differences were not significant. Furthermore, 
no differences in cell viability were detected, indicating that the 
magnetic fields did not lead to any observable apoptotic effect 
on studied 2D models.[116]
Limited studies on the application of magnetic fields on 
3D models have also been reported. For instance, Li et  al.[117] 
reported on the application of a non-mechanical actuation by 
imposing an external magnetic field on self-fabricated cell-
laden hydrogels (µMACs) in GelMA. µMACS were fabricated 
by developing a mold system composed of poly(methyl meth-
acrylate). Subsequently, a layer of poly(ethylene) terephtha-
late (PET) was used to cover the base of the mold, whilst the 
top part was covered with a photomask. To induce magnetic 
actuation on the constructs, the authors applied different 
strains (10, 20, 40 and 60%) on a mold coated with a mixture 
of poly(ethylene glycol) dimethacrylate (PEGDMA)/Fe3O4 par-
ticles. Finally, different GelMA solutions (10%, 15 and 20% 
w/v) containing C2C12 cells were pipetted on top of the mag-
netic layer. As a control system, a PEGDMA (10% w/v) sphere 
encapsulating just Fe3O4 nanoparticles (5% w/v) underwent the 
same magnetic fields (Figure  16A). Subsequently, after 6 h of 
encapsulation, both the muscle-like constructs and the control 
were magnetically stimulated for 10 h per day (10 days) using a 
NdFeB permanent magnet (Figure 16B). After 10 days of differ-
entiation in the 10% GelMA/PEDGMA magnetic hydrogel, the 
results showed successful myotube maturation and alignment 
within cell-laden constructs strained at 40%. In contrast, there 
were few differentiated myotubes with constructs strained 
at 60%, and no myotube development at all with constructs 
strained at 20% (Figure  16C). Moreover, higher mRNA levels 
of transcriptional regulators such as MHyC (≈0.1) for 3D con-
structs strained at 40%, in comparison with µMACs strained 
at 20% (≈0.01) and 60% (≈0.025). It was concluded that higher 
magnetic strains (40 and 60%) can enhance the maturation 
of differentiated myotubes. Nonetheless, in order to appro-
priately construct a closely packed array of healthy myotubes, 
40% strain was determined to be the best condition to provide 
appropriate external cues. These cues were determined to be 
able to trigger the required mechanobiological properties of 
encapsulated cells.[117]
Another report on the benefits of magnetic fields on SMT 
engineered constructs were published by Yamamoto et  al.[118] 
They cultured C2C12 cells in medium containing mag-
netite cationic liposomes (MCLs) for 8 h in order to induce 
the cellular uptake of the MCLs (100 pg/cell). Subsequently, 
MCL-labeled cells were seeded in an annular gap between 
the wall of a 24 well-plate and a fixed polycarbonate cylinder 
(12 mm  diameter) within the well, with a cylindrical neo-
dymium magnet (30 mm  × 15 mm)  providing the external 
magnetic field. Formation of a ring-cell shape structure was 
achieved after 2 days of cultivation, after which 0.1 mL  of 
ECM solution (collagen type I/Matrigel) was poured on top 
of the cells. After a further 4 h of culture, the cell-ring struc-
ture was placed on two stainless-steel pins in a 35mm culture 
dish to promote alignment via static strain, and myogenesis 
was induced by adding differentiation medium. Moreover, two 
carbon electrodes were placed on both sides of the petri dish 
and magnetic induction of 0.4 T was imposed using electrical 
pulses (15 V, 10 ms) for ≈20 days. Histological analysis showed 
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that the content of MCL particles did not affect cell viability 
of the 3D ring-like constructs, preserving stability of the con-
struct during magnetic stimulation. Furthermore, control sam-
ples without intracellular MCLs displayed cell-sheet formation 
around the magnet due to magnetic forces, forces that subse-
quently caused the control cells to detach from the ECM. At 
the completion of the experiment, there were clear myofiber 
formations on the MCL-labeled cells, arranged parallel within 
the cylindrical structure.[96]
Most of the conducted studies have shown in 2D systems 
that a minimum magnetic flux density of ≈10 T is required to 
boost the myofiber differentiation and subsequent alignment. 
However, α-actinin, F-actin and nuclei staining depicted sar-
comere formation within aligned myotubes, indicating that 
distribution of low magnetic fields (0.4 T) through the mate-
rial, resulted in beneficial results in stimulated cells. Indeed 
the contractile responses triggered by magnetic fields on 
developed 3D myotubes confirms the importance of exploring 
new alternatives in terms of external stimuli. In conclusion, 
magnetic fields are a powerful tool for the successful regen-
eration of skeletal muscle for both in vitro and in vivo models, 
especially as a non-invasive alternative to ES. There has been 
no report on DNA damages of cells after exposure to different 
magnetic fields thus far, and the techniques reviewed here 
have all significantly improved the proliferation and differen-
tiation capabilities of the various muscle fibers. However, the 
real mechanism of how such magnetic fields can impact the 
neuronal response within the muscle, and consequently how 
it will impact self-regenerative processes, is still under investi-
gation. An overview of all important parameters and obtained 
results for mechanical, electrical and magnetic stimulation of 
skeletal muscle cells is shown in Table 1.
4.4. Chemical Stimuli
In recent years, researchers have attempted to dissect the 
complex mechanisms involved in the proliferation and dif-
ferentiation of SMT via chemical stimulation. While the gen-
eral chemical pathways and the proteins that comprise them 
have been identified, there is still a lack of knowledge about 
how these pathways regulate themselves and each other. Addi-
tionally, many chemical techniques have been used to probe 
specific known signaling pathways. Researchers can further 
elucidate the contribution of each pathway over the myo-
genic behavior of the skeletal muscle cells. This section will 
focus on the researches that have used growth factors or other 
chemical stimulants to activate the robust regulatory pathways 
that maintain the crucial SMT functions, whether it be via 
increased proliferation of myoblasts or through the widening 
of muscle fiber diameters in tissue engineered structure.
Many studies assess the effects of growth factors on myoblasts 
and differentiated myotubes. Growth factors are signaling mole-
cules that impact most of the tissues in the body.[119] In SMT, there 
are different types of growth factors that appear at different times 
during skeletal muscle development, such as IGF, fibroblast 
growth factor (FGF), transforming growth factor (TGF), hepato-
cyte growth factor (HGF), and platelet-derived growth factor 
(PDGF).[119a,120] Each of these growth factors can have a variety of 
isoforms with unique impacts on skeletal muscle differentiation; 
for example, FGF-19 has been shown to cause important muscle 
hypertrophy alongside increased functional capabilities, whereas 
FGF-21 has been found to have no direct impact on the prolifera-
tion or differentiation of skeletal muscle cells.[121] The majority of 
the work on growth factors and their impact on muscle differen-
tiation has been reviewed elsewhere.[10,122]
Figure 16. Magnetic stimulation approaching 3D muscle-like systems. A) Schematic representation of cell-laden hydrogels stimulated magnetically 
using a non-contact magnet, B) Viability percentage and Live/dead fluorescent images of C2C12 cells stretched on µMACs with different GelMA 
concentrations (10, 15 and 20 w/v%) displaying correspondent elastic moduli (6, 10, and 20 kPa) and C) Confocal fluorescent images of magnetically 
oriented myotubes within µMAC s (GelMA 10%) at different strains (20, 40 and 60%). Adapted with permission.[117] Copyright 2016, Springer Nature.
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Table 1. Overview on important parameters and obtained results for mechanical, electrical and magnetic stimulation.
Type of 
Stimuli
Device Voltage (V) Frequency 
(Hz)




Type of cells/tissue Results Ref.
MS Externally mounted 
stimulator with stainless 
steel electrodes
N/A 10 N/A N/A 3 Soleus muscle hind limbs 
(Rabbits)
. Rapid activation of myosin heavy 
chain.
. Production of slow, type I and fast 
oxidative IIA fibers
. Loss of tissue mass started to 
appear for constant stretching
[91]
MS Flexercell FX-4000 
Tension Plus System
N/A 0.6 –10 (CSDS)
8 h
–6 (ALDS) 60 s
N/A 4 NHDF monolayer on 
Bioflex membrane and 
C2C12 monolayer on 
petri dish
. Fibroblast layer induces higher 
expression of different cytokines on 
C2C12 cells.
. higher myogenesis due to the co 
culture
[92]
MS Self-made culture device 
(Gripper for hydrogel 
fibers, actuator by 
stepping motor)
N/A 1 3 N/A 2 C2C12 encapsulated 
in core–shell collagen 
hydrogels.
. Core–shells hydrogel led to mim-
icking muscle fibrous structure.
. Random alignment on 2D systems 
was overcome by constant mechan-
ical stretching.
. Elongation through the fiber axis 
due to external stimulation.
[94]
MS MagneTissue (Self-made 
bioreactor)
N/A N/A 10 N/A ≈10 C2C12 cells encapsulated 
in fibrin gels.
- after 3 days of MS mature tissue 
was formed
. Cell alignment enhanced by strain-
effect transmission.
. Significant expression of MyoD and 
Myogenin markers.
[93]
MS Self-made bioreactor N/A 0.5 ≈2 (Static vs 
Constant)
N/A 13 C2C12 cells seeded on 
microfibrous DegraPol 
strips.
. Significant reduction in MHC 
expression for static stimulation in 
comparison with cyclic models.





39 ± 14 V N/A N/A N/A 7–10 15 muscle biopsies 
(vastus lateralis) from 
15 old patients.
. Higher expression of Ca2+ proteins.
. Muscle restoration achieved on 
soleus and VL muscle
[102]
ES C-Pace Culture Pacer 
(IonOptix)
4 V cm−1 6 N/A N/A 2–3 3D bioarticial muscle 
(mBAMs)
. Sarcomeric production leading to 
contraction at given frequency.
. No striation achieved on 2D systems 
in contracts with high striations levels 
obtained on 3D stimulated scaffolds
[104]
ES Self-made electrical 
stimulator
N/A 1 N/A N/A 6–10 C2C12 myotubes on 
top of an atelocollagen 
membrane




ES Carbon flat electrodes 
(BMK Designs)
40 V cm−1 N/A N/A N/A 8 Human myoblasts on a 
Matrigel/fibrin solution
. Reduction in oxygen consumption 
due to hydrogel presence.
. Significant improvement in muscle 
cells respiration
[105]
ES Pulse stimulator 0.7 V mm−1 5, 10 and 
20
N/A N/A ≈10 Muscle skeletal bundles 
around PEDOT/PU wire 
films
. Sarcomeric expression.
. No significant cellular damage.
. Monocyte chemoattraction
[107]
ES Self-made PDMS 
chamber for conducting 
ES using LabView.
N/A 1–10 N/A N/A ≈20 Myobundles (iSKM) . Significant increase of nuclei and 
cross sections for 3D constructs in 
contrast with 2D cell systems.
. Rapid sarcomeric development and 
larger myotube
[106]
Magnetic Biocon 2000 W N/A 10 and 50 N/A N/A 5 Injury in Quadriceps from 
C57 mice
. Faster restoration of injury (Higher 
cross-sections formation).
. Lack of hyperthropy due to absence 
of stimulation.
. Higher expression of MHC levels
[112]
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Growth factors and proteoglycans, such as agrin, are also 
attractive for use in SMT engineering, as they are capable of 
activating signaling cascades that are known to regulate the 
development of mature, functional myotubes. IGF-1 in par-
ticular has been well-noted as a promoter of myoblast differ-
entiation and the hypertrophy of differentiated myotubes; in 
recent years, the exact mechanisms of IGF-1 have been con-
firmed as operating via the mitogen-activated protein kinase 
(MAPK) and phosphatidylinositol 3-kinase (PI3K) signaling 
pathways.[123] Both of these pathways are crucial for the suc-
cessful development of functional myotubes in vitro and in 
vivo, highlighting IGF-1 as a potentially important growth 
factor to include as a part of therapies. Other therapies have 
included agrin in 3D bioengineered artificial muscles (BAMs), 
in an attempt to create mature AChRs on the periphery of the 
differentiated myotubes.[124] These BAMs were constructed by 
culturing green fluorescent protein-transduced CH3 mouse 
myoblasts between two silicone posts, allowing for aligned, 3D 
tissues to form. After 14 days of culturing, Wang et  al. placed 
6 µL 1 U mL−1 of agrin into a solution of differentiation media; 
agrin is noted in literature as having a positive impact on AChR 
clustering in myofibers, which is an important physical charac-
teristic of mature, functional muscle fibers. The treatment of 
agrin caused a 7.3-fold increase of AChR clustering in the BAM, 
however these AChRs were notably immature in both size and 
morphology.[124] Likewise, the MHC isoform content of the 
BAM was primarily perinatal and embryonic. The ever-present 
issue of immature myofiber phenotypes requires more work to 
resolve, than these experiments have provided.
Insulin-like growth factors, which include IGF-1, are peptide 
growth hormones that assist in the formation of mature myo-
tubes during the later stages of embryogenesis as well as in the 
regeneration of damaged muscle fibers.[10,123,125] Recent studies 
have found that IGF-1 and HGF work via the p38 MAPK and 
PI3K pathways to activate satellite cells for muscle repair after 
an injury, while a daily injection of recombinant FGF-19 over 
7 days has been found to promote the phosphorylation of extra-
cellular-signal-regulated protein kinase 1/2 (ERK1/2) in adult 
murine models.[10,121b] ERK1/2 is part of another important cas-
cade mechanism, which can promote either the proliferation of 
satellite cells or the differentiation of those cells into myotubes, 
depending on how prolonged the pathway activation is.[126] 
The intricacies of these pathways have been slowly revealed 
in recent years, allowing increasingly targeted therapies to be 
attempted on both in vitro and in vivo diseased and atrophied 
muscle models.
Growth factors affect the expression of key MRFs in different 
ways, which is important when considering which growth fac-
tors to include in specific therapies. While FGF-19 promotes 
activation of satellite cell populations and induces hypertrophy 
in adult mice models, it has no impact on the expression of 
the various MRFs; the same is true for HGF and PDGF.[10,121b] 
IGFBP-6, however, was able to upregulate MyoD, Myogenin, 
and total MHC levels in pediatric mesenchymal stem cells 
(PMSCs)[119b], while IGF-1 is likewise known to increase the 
expression of MHC and tropomyosin, resulting in more mature 
muscle fibers.[119a] By utilizing these growth factors, researchers 
can use the natural signaling pathways of the body to assist 
with tissue engineering approaches.
Apart from growth factors, researchers have used other ther-
apies inspired from different chemicals used in natural skeletal 
muscle development and maintenance in order to potentially 
build up a portfolio of singular techniques that, although rel-
atively limited in their individual therapeutic potential, can 
be used in tandem to great effect. Researchers have assessed 
the impact of specific chemicals already utilized in various 
natural processes, such as calcium[14a], thyroid hormones,[16] 
and choline[127] on muscle development. Various studies in 
Type of 
Stimuli
Device Voltage (V) Frequency 
(Hz)




Type of cells/tissue Results Ref.
Magnetic Custom-made 
4 cm × 4 cm 
Neodymium magnetic 
plaques
N/A N/A N/A 80 mT 5 Static magnetic fields 
(SMF) on mammal 
skeletal muscle cells (L6).
. Faster alignment after differentiation 
for stimulated myotubes in contrast 
with non-stimulated ones, due to an 




4 cm × 4 cm 
Neodymium magnetic 
plaques
N/A N/A N/A 80 mT 12 Static magnetic field on 
myoblasts/mesenchymal 
stem cells coculture.
. No significant difference among 
stimulated and non-stimulated cells 
in the expression of Myf5 marker.
. AB confirmed higher proliferation 
rate for stimulated cells
[115]
Magnetic Magnet bore 
(150 mm × 900 mm)
N/A N/A N/A 0–10
Gradient: 
0–41.7 T m−1
6 C2C12 mouse-derived 
cells
. No effect on cell proliferation or 
myogenic differentiation.
. No myotube orientation at 3 T
[116]
Magnetic NdFeB permanent 
magnet
N/A N/A 10, 20, 40, and 
60
N/A 10 Self-fabricated cell-laden 
hydrogels (µMACs).
. Reduction of cell viability in GelMA 
20% strain
. Less myotube formation at 60% 
strain.
. Higher expression of mRNA regula-
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the past two decades have found success in increasing the 
muscle mass of both young and old mice models via the use 
of β-adrenoceptors, specifically the β2-adrenoceptors found in 
SMT.[128] β-adrenoceptors are a specific type of G-protein cou-
pled receptor that operate in a multitude of signaling pathways 
throughout the body; in skeletal muscle, the β-adrenoceptor 
isoform that is most commonly seen is the β2-adrenoceptor.[129] 
β2-adrenoceptors use G-proteins to activate the PI3K-Akt sign-
aling pathway, which utilizes an amalgamation of other pro-
teins and signaling molecules in order to activate mTOR and 
other transcription factors.[130] Previously, this isoform has been 
activated through chemicals such as fenoterol, a β 2-arenoceptor 
agonist which has unfortunate protein degradative side effects 
as well as problematic off-target impacts, both due to the rel-
atively long exposure times required for desired results.[131] 
Hagg et  al.[129] were able to bypass the usage of agonists such 
as these, and their side effects, by using recombinant adeno-
associated virus-based vectors (rAAV) for β2-adrenoceptor gene 
delivery. Through a single injection of 1 × 1010 of the rAAV:β2-
adrenoceptor genomes, the authors were able to induce a 22% 
increase in the muscle mass of tibialis anterior muscles of adult 
mice, which maintained for the duration of their 84-day long 
experiment; this is equivalent to the increase in muscle mass 
that was seen with 28 days of repeated formoterol treatment.[129]
Some researchers have made significant improvements on 
muscle differentiation by changing standard culturing proce-
dures in vitro, while others have experimented with altering 
the dosage of known inducers of muscle atrophy in order to 
promote myotube formation. While the gold standard for dif-
ferentiation media traditionally contains streptomycin with 
25 mm of glucose, Khodabukus and Barr reported on how low-
ering the glucose levels to 10 mm and removing streptomycin 
might impact muscle development.[132] They found that total 
MHC decreased with 10 mm  glucose levels supplemented 
with streptomycin, compared to the traditional 25 mm glucose 
found in control media. However, MyoD levels were higher in 
conditions where glucose was decreased, while Myogenin was 
expressed more under the traditional, high glucose conditions, 
whereas Myf5 and MHC isoforms were not significantly dif-
ferent among any of the groups.[132] In fact, streptomycin has 
been found to decrease force production in bioengineered 
C2C12 constructs, by causing a fast-to-slow SERCA isoform 
shift.[3] This, combined with streptomycin’s abilities as a cal-
cium blocker for muscle cells, creates a narrative where it is 
difficult to consider including streptomycin in experiments 
without taking these characteristics into consideration.
Similarly, the effect of the dosage of dexamethasone (DEX) 
on differentiation of C2C12 mouse myoblasts was investigated 
as DEX is known to induce muscle atrophy at high doses[121b,133] 
Immunocytochemical analysis showed sarcomere development 
in samples treated with 10 mm of DEX at day 6 of muscle cul-
ture, whereas few sarcomeres were formed in controls without 
DEX.[133]
4.5. Biological Stimuli
In SMT engineering, it has been important to try to use as 
many tools as possible in order to learn more about what exact 
stimuli myoblasts require in order to successfully differentiate 
into mature, functional myotubes. In vivo, a crucial amount of 
information is taken by the differentiating myoblasts from the 
cellular environment around them; this information is derived 
from the types of cells that constitute that environment, as 
well as from the materials they extrude into the ECM.[9,134] By 
including different types of cells, such as fibroblasts or MNs, 
into skeletal muscle stimulation methods, researchers have 
been able to theorize exactly what effects these cells will have 
on the proliferation and differentiation of skeletal muscle cells. 
For example, fibroblasts are cells that act in predominantly sup-
porting roles throughout the body, including in SMT. They have 
been a target of research by tissue engineers due to the matrix 
materials, such as collagen, that they frequently lay down fol-
lowing an injury.[135] In vitro cocultures of fibroblast and myo-
blasts are not entirely new concepts, as they have seen success 
in the creation of 2D and 3D muscle organoids in the past few 
decades.[136] In recent years, however, their role in the develop-
ment of functional SMT has been further elucidated, due to the 
dedicated continuation of crucial coculture studies.[137]
During the muscle repair process after an injury, the wound 
site is typically flooded with a variety of cells, including mac-
rophages, fibroblasts, and regenerative satellite cells.[20b] These 
cells have a significant impact on myogenic migration and 
proliferation in vitro if cultured together, as reported by Venter 
et  al.[138] Their experiments investigated the proliferative and 
migratory effects on myoblasts, compared between three exper-
imental groups: myoblast/macrophage cocultures, myoblast/
fibroblast cocultures, and a triple coculture with all three cell 
types. In individual cocultures, fibroblast cells would promote 
the migration of myoblasts whereas macrophages could only 
promote their proliferation. Specifically, the promoted migra-
tory effects seen in the myoblast/fibroblast coculture were not 
reproducible in the triple coculture, indicating that particular 
response was inhibited in some way by the presence of the 
macrophages.[138] The exact mechanisms for these responses 
are as of yet unknown.
Myoblasts are not only impacted by other cell types, but 
they have been shown to be impactful in their own rights. Fry 
et al.[139] performed an in vivo analysis of fibroblasts and myo-
blasts in a model of early hypertrophy. Their results indicate 
that the early presence of myoblasts could lessen the amount 
of fibrotic collagen produced by fibroblasts, even if those myo-
blasts are only present for a short period of time.[139] If the goal 
is to replace and repair damaged muscle fibers with functional 
adult myofibers, then tissue engineers must focus on the tech-
niques that reduce and prevent fibrosis just as they must focus 
on those that promote healthy myogenesis. Myofibroblasts, 
however, have been shown to interact with C2C12 cells in 3D 
cocultures in a positive way; Krieger et  al.[140] indicated that, 
when compared to mono-cultures as well as fibroblast/myo-
blast cocultures, myofibroblast/myoblast cocultures produced 
myotubes that were distinctly thicker and more multinucle-
ated. This more mature morphological phenotype implies that 
myofibroblasts promote the differentiation of myoblasts signifi-
cantly when cultured together, than monoculture.[140]
In order to provide the appropriate amount of energy needed 
for skeletal muscles to function, a highly integrated vascular 
system is required. Vascular cells, such as endothelial cells, 
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have a robust relationship with the satellite cells, myoblasts, 
and myotubes that comprise the muscular system.[141] The lack 
of a vascular network in large, engineered muscle tissues, both 
in vitro and in vivo, frequently results in necrosis and tissue 
failure. Therefore, the diffusion limit of oxygen and other nutri-
ents in the absence of a vascular system is one of the single 
most important barriers for the development of in vitro skel-
etal muscles, as well as for the field of tissue engineering as a 
whole.[142] Angiogenesis, or the vascularization of bulk tissues, 
is a complex and multi-faceted process, and is far outside the 
scope of this review; however, the inclusion of endothelial cells 
into co-cultures with myoblasts is an ever-evolving part of skel-
etal muscle tissue engineering, and should be discussed here.
Current knowledge about the exact crosstalk pathways that 
endothelial cells and myogenic precursors utilize in their syn-
ergistic dialogues is, unfortunately, lacking. Researchers have 
known for decades that the connection between endothelial 
cells and muscle satellite cells goes beyond their close spatial 
proximity; these two cell types coordinate to each promote the 
migration, proliferation, and differentiation of the other.[141] In 
recent years, these cells have been re-introduced to each other 
in vitro to further investigate how far this coordination can 
potentially go. Gholobova et al.[61] introduced human umbilical 
vein endothelial cells (HUVECs) to their BAM model in 2015, 
in an attempt to pre-vascularize their muscle constructs. Their 
results indicated that a 70:30 or 60:40 ratio of human muscle 
cells to HUVECs promoted the proliferation and alignment of 
the resultant myofibers significantly more than a simple 50:50 
ratio. These myofibers, however, were cultured in endothelial 
growth media (EGM), in order to maintain both cell populations 
without rampant cell death. These myofibers had no cross-stri-
ations visible after 7 days of co-culture, potentially due to the 
lack of muscle-specific growth or differentiation media or to 
the short culturing time frame.[61] Latroche et al.[143] investigated 
whether media, conditioned by endothelial cells, could poten-
tially carry some of their benefits when this conditioned media 
is cultured together with human myoblasts. Their 2017 study 
found that endothelial cell-conditioned media promoted the pro-
liferation and myogenin expression of human myoblasts; how-
ever, no other MRFs were analyzed outside of myogenin, and 
the overall maturity of the resultant myofibers is not known.[143]
Due to the inherent dependency that myofibers have on 
electrical stimulation, MNSs have also been identified as an 
important biological factor to consider in skeletal muscle devel-
opment. MNs taken from the ventral spinal cord in particular 
have had a history of successful cocultures with skeletal myo-
blasts.[144] As MNs attach to myofibers, they form NMJs, which 
have been successfully formed in 3D coculture experiments 
in vitro and subsequently used to stimulate myofibers both 
chemically and electrically.[98,145] Unfortunately, these methods 
of stimulation frequently result in phenotypically immature 
myofibers, as the neural networks formed between MNs and 
myoblasts do not provide enough stimulation to promote 
mature myogenic differentiation.[146] Bakooshli et  al.[147] inves-
tigated this with a set of experiments culturing MN clusters 
onto 3D fibrin/Geltrex hydrogels seeded with human myogenic 
progenitor cells and human fibroblast-like cell lines. After two 
weeks of culture, the 3D hydrogel environment had promoted 
thicker, more functional myotube formation alongside greater 
neurite regrowth from the MN clusters than the 2D controls. 
This triple coculture provided an optimal environment for the 
formation of aligned myotubes with detected neurite regrowth 
into AChRs; unfortunately, without data on the specific MHC 
isoforms, it is unclear whether or not the coculture produced 
myotubes with mature phenotypes.[147]
While traditional coculturing methods have had cell-to-cell 
contact, the advent of microfluidic devices allows researchers to 
provide some segregation to their cell populations, mimicking 
the in vivo environment while still retaining the benefits of 
coculturing two different types of cells together.[148] Uzel et al.[149] 
reported on the development of one such microfluidic device 
that used traditional C2C12 myoblasts along with gene-edited 
MNs that were susceptible to optical stimulation. By optically 
stimulating the MNs in one well of their device, the researchers 
could see a contractile twitch response in the myofibers of the 
other well. Immunostaining confirmed the presence of striated 
sarcomeric structures, presumably promoted and enhanced 
by the presence of the stimulating neural network.[149] Zahavi 
et al.[150] performed a similar study with their own microflu-
idic neuromuscular coculture, and found that the contractile 
behavior of innervated myotubes is significantly stronger and 
more frequent than that of non-innervated fibers.[150–151]
Monitoring the Ca2+ fluxes in myofibers in response to stimu-
lation via neural networks is increasingly important to dissect 
the impact that MNs have on the determination of myofiber 
phenotype. Juhas et al.[152] published a method to analyze these 
fluxes in real time through the use of a dorsal window implan-
tation in a rat model. They implanted differentiated and un-
differentiated skeletal muscle constructs into a dorsal skinfold 
window, together with the introduction of an intracellular Ca2+ 
sensor that could be measured via the window. Post-implanta-
tion analysis indicated that previously-differentiated myofibers 
produced significantly larger myofibers than the un-differenti-
ated samples. Their subsequent significantly higher force pro-
duction capabilities were attributed to increased Ca2+ fluxes, 
along with an ingrowth of new blood vessels from the host.[98,152]
4.6. Combinations of Multiple Stimulation Methods
Thus far, in this review, important research has been high-
lighted that focuses on specific methods of external and 
internal stimulation of SMT. While each published report helps 
to clear the way for future research, the ultimate success of 
these endeavors will not be built on the backs of any individual 
method; it will be the cumulation of these techniques, rather, 
that will be the key to developing useful and critical tissue engi-
neering strategies for skeletal muscle regeneration. This next 
section focuses on the recent work that has found interesting 
and successful ways of bringing together multiple methods of 
skeletal muscle stimulation in order to promote appropriate 
muscle growth in vitro and in vivo.
4.6.1. Biological and Topographical Co-Stimulation
As discussed previously, the inclusion of different cell types 
in coculture studies with skeletal muscle progenitors has 
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shown researchers that biological entities such as fibroblasts, 
endothelial cells, and chemical growth factors have a positive 
effect on the proliferative and myogenic properties of myo-
blasts.[98,139,148,151,153] These studies have been carried forward 
and enhanced using techniques that provide mechanical 
stimuli in addition to studies with coculture, in an effort to fur-
ther enhance their promyogenic results. Since the promotion 
of alignment is such a crucial aspect in mechanical stimula-
tion studies, researchers have used micro-grooved substrates to 
promote the alignment of various myoblast cocultures.[2,145,154] 
Ko et al.[145] advanced neural and muscle cocultures by plating 
primary myoblasts and neural stem cells together onto a micro-
grooved poly(urethane acrylate) (PLA) substrate, which was 
coated with Matrigel to promote cell attachment, shown in 
Figure 17. The authors found that the 1600 nm grooves in the 
substrate promoted the anisotropic alignment of the myoblasts, 
with the additional benefit of parallel axon ingrowth into the 
subsequently differentiated myotubes. This structure proved to 
be significantly more sensitive to chemical stimulation than an 
equivalent coculture plated on a simple flat surface.[145]
Similarly, a chitosan-coated surface was used to promote the 
attachment of fibroblasts and primary myoblasts, in an effort 
to promote beneficial organization of F-actin and integrin β, 
both key players in skeletal muscle regeneration.[155] The inclu-
sion of chitosan-coated plates in the coculture study promoted 
the proliferation of myoblasts while simultaneously inhibiting 
the attachment of fibroblasts, which is the preferred result for 
applications using 1:1 cocultures of fibroblasts and myoblasts. 
By slightly inhibiting the attachment of fibroblasts, the chitosan 
coating inhibits the fibrotic tissue formation which frequently 
results in nonfunctional scar tissue. Unfortunately, this study 
did not look at the effects that this substrate had on the differ-
entiation of these myoblasts.[155b]
Ito et  al.[156] also progressed their own previous work that 
had studied the effects of IGF-1 on myoblast differentiation, 
through the use of gene-edited myoblasts and the addition of 
DOX. They attempted to culture the same gene-edited myo-
blasts onto various cultured surfaces that were each coated with 
a particular ECM protein, such as fibronectin, type I collagen, 
laminin, and type IV collagen. In the presence of DOX, these 
cells had the most improved motility and proliferation on type 
IV collagen-coated surfaces; unfortunately, none of the surfaces 
significantly changed the differentiation rates or myotube struc-
tures once the myoblasts were differentiated. However, the pro-
moted proliferative responses do correspond to a more mature 
phenotype, and the additional over-expression of IGF-1 caused 
by the addition of DOX was able to still promote differentiation 
over controls.[156a] This work, along with additional work using 
VEGF-gene edited sheets to promote muscle differentiation, is 
a promising step to the development of robust in vitro differen-
tiation techniques.[157]
In recent work, there has been an influx of skeletal muscle 
studies done on substrates patterned through a variety of fiber-
spinning techniques.[39,52,154a-d] In 2018, Ebrahimi et  al. used a 
microfluidic spinning apparatus to create defined, micropat-
terned substrates using GelMA hydrogel fibers.[39] By culturing 
C2C12 myoblasts onto this micropatterned surface with the 
addition of 100  ng mL−1 of agrin, they were able to produce 
C2C12 with a higher percentage of AChR clusters, regardless 
of whether the GelMA fibers were extruded with a defined 
micropatterned surface or as nonpatterned fibers. Interestingly, 
this experiment also showed that agrin promoted the differenti-
ation of myoblasts into functional myotubes with higher ampli-
tudes of contractions, further confirmed by an increased expres-
sion of sarcomeric actin, Myogenin, and fast type IIx MHC.
4.6.2. Electrical and Mechanical Co-Stimulation
Mechanical techniques are particularly applicable in combina-
tion with electrical methods, as their stimulation methods are 
typically on similar timescales and can be done using similar 
equipment.[158] Recent research has pointed to particularly 
interesting results involving out-of-phase co-stimulation, such 
as the work done by Kim et  al. showing the correct propaga-
tion of the impulses and contractibility responses exerted by the 
myotubes.[158] They found that engineered 3D fascicle-inspired 
muscle constructs (C2C12 myoblasts mixed with fibrinogen and 
Matrigel) had 31% better functional performance after 20 min-
utes of co-stimulation, where a mechanical cantilever would 
induce 2.3% strain until an electric potential was administered. 
The electric potential produced an electric field of 2.5 V mm−1 
Figure 17. Primary myoblasts are plated onto micro-grooved patterns and differentiated. Following differentiation, neural stem cells were cocultured on 
top of the myotubes and differentiated into neural networks. Adapted  under the terms of a Creative Commons Attribution 4.0 International License.[145] 
Copyright 2019, The Authors, published by Wiley-VCH.
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by two platinum wires with bipolar pulse of 1 ms, structured to 
be combined with the mechanical stimulation at a 180° phase 
shift.[158] (Figure  18A). Immunostaining results depicted that 
co-stimulation system led to a larger striation of α-actinin, due 
to the enhancement in the transmission of external stimuli that 
triggered internal contraction forces of the myotubes within 
the 3D-fascicles. Constant muscle stretching produced by the 
cantilever directed a faster propagation of the electrical pulses. 
Co-stimulation was applied at different frequencies (0.1, 0.23, 
and 0.45  Hz) finding that 0.23  Hz showed a better stimula-
tion response. Furthermore, when it was compared with single 
ES and MS, there was a significant improvement in the way 
tissue maturation was achieved. Co-stimulated samples showed 
the production of well -aligned fibers, while single-stimulated 
3D constructs showed significantly fewer benefits in the ori-
entation of actin filaments after 3  min (Figure  18B). Overall, 
alternating applications of MS and ES resulted in higher con-
tractibility responses (20%) in contrast with individual stimula-
tion, indicating that the initial mechanical stretching somehow 
impacted how the electrical current was transferred towards 
those myofibers enclosed in the Matrigel/fibrin gel.
In recent years, however, the conversation has also begun to 
include various aspects of nanotechnology, such as nanoparti-
cles and nanotubes.[159] Boron nitride nanotubes were used to 
increase the myogenic differentiation effects in response to 
ultrasound stimulation in C2C12 myoblasts during an inter-
esting coculture study performed by Ricotti et al.[154a] Since 
boron nitride nanotubes are capable of inducing an electrical 
stimulus in response to stress, the authors used ultrasound 
sources at 40 kHz for 10 seconds a day to upregulate MRFs and 
MHC conversions during differentiation. Moreover, Ostrovidov 
et al.[1b] demonstrated fabrication of aligned electrically conduc-
tive hybrid fibers from gelatin and multi-walled carbon nano-
tubes (MWNTs) to enhance the formation of aligned myotubes 
with improved contractibility. The improved mechanical proper-
ties of the resulting 20% gelatin fibers due to the presence of 
0.5  mg mL−1 and 5  mg mL−1 MWNTs improved the myotube 
formation by comparing 20% gelatin fibers and hybrid fibers. 
Variable mechanical properties and electrical conductivity 
of fibers resulted in upregulation of the activation of mech-
anotransduction-related genes. However, this alone was not 
able to achieve the maturation required for these constructs 
to resemble native, mature muscle tissue; therefore, the func-
tion of the muscle tissue grown on these fibers was further 
improved upon by applying additional continuous electrical 
pulses. Myotube contraction was analyzed after 4 days culture 
in differentiation medium and 2 additional days accompanied 
with electrical stimulation (5  V, 1  Hz, 1  ms duration). They 
observed by increasing the MWNT concentrations myotubes 
with higher maturation and contractibility were formed and 
the myotubes which were cultured on 20% gelatin fibers with 
0.5 mg mL−1 MWNTs continuously contracted even after ES was 
OFF for more than 10 min indicating a high level of maturation.
The inclusion of electrical stimulation and mechanical 
stimulation, along with advancements in nanotechnology, 
has already bore important fruit, and it will be a key focus of 
research in the coming years to deduce specific mechanisms 
for the MHC isoform conversions that cause these differences 
in myofiber maturity.
4.6.3. Electrical and Biological Co-Stimulation
Electrical stimulation studies have also been combined with 
biological co-cultures.[159f,160] Takahashi et  al. took this work 
one step further, by using a stepwise experimental design to 
first induce myotube alignment prior to the use of electrical 
pulse stimulation (EPS).[161] The researchers first cocultured 
human dermal fibroblasts and human skeletal muscle myo-
blasts onto a thermoresponsive, micro-patterned acrylamide 
surface to induce alignment. These cells would then peel off 
at low temperatures and would be introduced into a Matrigel-
containing fibrin gel; after seven days of differentiation in this 
gel, they would undergo electrical stimulation (10 V,  1 Hz, 
3 ms duration) using a commercial C-Dish device (IonOptix) for 
two weeks post-differentiation. After two weeks of EPS, they 
found a significant increase of myotube diameter compared to 
control, with no significant difference between duration times 
used.[161] Confocal microscopy confirmed that contractions 
responses triggered in Matrigel/cell sheet system led to more 
aligned myofibers, with expression of laminin and Col IV in 
contrast with the random alignment of control sample which 
was a stimulated cell sheet cultured on an nonpatterned sur-
face without Matrigel layer. Their work confirms work done 
by Ostrovidov et al. in 2014 in a similar experiment.[146a] Ostro-
vidov et al. used a micropatterned GelMA coculture system in 
combination with EPS, but with C2C12 and PC12 neural cells 
cocultured instead of fibroblasts and myoblasts. They applied 
Figure 18. A) Schematic representation of co-stimulation of skeletal muscle constructs, consisting of parallel electrodes for applications of electrical 
potential and cantilever wire moved by a servomotor in order to stretch sideways using the desired strain. B) Fluorescent images of well-aligned col-
lagen (red) and actin (green) fibers obtained after ES (5 µm) and performance improvement obtained in the levels of contractile forces achieved by 
individual stimulation in contrast with co-stimulation approach. Adapted with permission.[158] Copyright 2019, Nature Springer.
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an electrical pulse (6 V, 1 Hz, 1 ms duration) for two days, and 
characterized changes in MRF expression due to the combi-
nation of enhanced alignment and induced EPS. The authors 
found that the co-culturing of C2C12 myoblasts with PC12 cells 
improved myotube formation and upregulated Myf5, MHC-IIx, 
MHC-IIb, and MHC-neo; they also found that the combined 
electrical stimulation significantly boosted those results even 
further.[146a]
4.6.4. Magnetic and Mechanical Co-Stimulation
In terms of potential impact, the combination of magnetic 
particles and SMT engineering strategies seems a perfect 
match; skeletal muscle is a type of tissue that requires align-
ment and responds nicely to stimulation methods that pro-
vide a direction of force, and magnetic particles are capable of 
providing such a force via external magnetic fields. Particles, 
both magnetic and non-magnetic, have been successfully 
used in skeletal muscle studies to improve differentiation in 
3D hydrogel environments.[159b,162] Tognato et al.[163] published 
a report that utilized iron oxide nanoparticles in a GelMA 
hydrogel to enhance myotube alignment and differentiation, 
as shown in Figure 19.[163] The iron oxide nanoparticles, once 
stimulated via an external magnetic field, produced aniso-
tropic lines inside of the hydrogel; these anisotropic forma-
tions induced better alignment from the myoblasts embedded 
inside GelMA.[163] Even without differentiation media, the 
myoblasts were able to differentiate into myotubes with high 
cell numbers; unfortunately, no MHC isoforms were charac-
terized, and therefore the phenotypes of those resultant fibers 
are unknown.
As always, the results of these experiments are difficult to 
compare with one another, due to the wide range of applica-
tions, hypotheses, and questions that these authors were 
attempting to resolve. For SMT engineering, the underlying 
constraint remains unanswered; the muscle fibers that are 
created in vitro and in vivo are still phenotypically immature. 
These myofibers are still predominantly composed of MHC-
neo isoforms, with contractile behaviors that are still orders of 
magnitude beneath those of native myofibers. Nonetheless, the 
research that has been completed in recent years has made sig-
nificant progress towards the potential development of mature 
phenotypes, through the combined use of mechanical, electric, 
biological, and magnetic techniques.
5. Outlook
Recent years have seen advancement of fabrication and devel-
opmental techniques in formation of more complex models of 
human skeletal muscle with higher similarity in functionality 
and mimicking the physiological subtleties of native tissue. 
Applications of these developed models with multicellular 
structure range from more accurately modelling disease, to 
generating tissues for transplantation in VML. Mimicking the 
in vivo conditions in vitro, such as by applying various loadings 
or electrical impulses, as well as coculturing with supporting 
cells enables further maturation of the tissue. However, the 
field is yet in its infancy and there are still unanswered ques-
tions about the combinatorial effects of materials, regulators 
and cells on muscle maturation processes to form more repre-
sentative human tissue models.
The question of how the muscle tissue will be connected to 
the native tissue after transplantation has to be faced in future 
studies. As it has been shown in this review, the progress that 
has been made mostly is focused on improving the function of 
the in vitro grown tissue. For medical applications like trans-
plantation there are more factors to be considered. Moreover, 
to avoid necrosis of the tissue, the provision of nutrition and 
oxygen to the in vitro grown muscle tissue is essential and can 
be achieved by vascularization before implantation. Despite the 
efforts made until now, a permanent connection between native 
and implanted tissue could not be established.[164] Similarly, 
Figure 19. Iron oxide nanoparticles are suspended into a GelMA matrix A) and subsequently placed in an external magnetic field B). The magnetic 
particles form anisotropic lines along the magnetic field lines C) and can be bioprinted D) and crosslinked E) to form the desired substrates. Adapted 
with permission.[163] Copyright 2018, Wiley-VCH.
Adv. Mater. Interfaces 2021, 8, 2001167
www.advancedsciencenews.com
www.advmatinterfaces.de
2001167 (30 of 35) © 2020 The Authors. Advanced Materials Interfaces published by Wiley-VCH GmbH
the connection of the native nervous system to the transplanted 
tissue is paramount to achieve simultaneous contraction of 
both native and transplanted tissue and thus functionality. This 
issue has not been solved yet, although research shows progress 
in co-cultivating skeletal muscle cells and neuronal cells.[165]
As outlined above, the SMT engineering field has devel-
oped greatly in the last 10 years, moving forward to creating 
ever-increasing complexity and biomimetic tissues. In the 
next 10 years, we believe research on generating functional 
SMT research will focus on four major gaps. i) Production of 
multicellular tissues with similar functionality and contrac-
tion-induced forces equivalent to native tissue. Redesign of 
platforms for combinational stimulation and coculturing will 
result in maturation of tissue architecture. ii) Development of 
strategies for vascularization of engineered tissues to enable 
transport of nutrients, oxygen and soluble factors to cells, 
and thus facilitate the formation of larger engineered skeletal 
muscle constructs. iii) Modelling multi-tissue and multi-organ 
constructs. The development of multilineage organoids which 
can self-assemble vastly increases the potential of formation 
of multicellular structure with similar complexity as human 
muscle tissue. iv) Advancement in application of the SMT 
models for drug screening purposes which is less advanced 
than for cardiac and other tissues.[166] Further challenges exist 
to translate the outcomes of research studies to commercial 
manufacturing and widespread clinical application, including 
achieving scale-up, reproducibility and regulatory approvals.[167]
Apart from the medical applications, which were the main 
focus of this paper, growing skeletal muscle tissue is also attrac-
tive for other industries, particularly in the pharmaceutical and 
food sectors. Biomimetic engineered tissues open opportunities 
for high throughput and personalized drug screening to reduce 
the need to animal testing, accelerate the successful translation 
of drugs to clinic, and optimize patient outcomes. As skeletal 
muscle tissue engineering continues to progress with the incor-
poration of biologically meaningful stimuli, it can be envisaged 
that improvements in the in vitro–in vivo correlation of drug 
responses may also improve, and engineered tissues have the 
potential to reduce and ultimately potentially replace animal 
testing. Companies like Cytokinetics, Sarpeta Therapeutics and 
Solid Biosciences are developing approaches for disease and 
patient specific drugs. The focus is not only on the develop-
ment of genetic and medical approaches but also on devices for 
the most common muscular and neuromuscular diseases.
Furthermore, global demand for protein-based foods is 
growing rapidly and muscle tissue engineering is attracting 
increasing interest as a source of artificial meat. The production 
of artificial meat replacements in the laboratory is an emerging 
industry to provide ethically preferably alternatives to meat 
from conventional farming. The importance of the produc-
tion of artificial meat arises not only due to the tremendous 
increase in demand for animal-derived proteins but also to the 
major contribution of animal agriculture in ≈10% of production 
of greenhouse gas emissions in the US alone and 37% of all 
methane emissions globally.[168] The term artificial meat can 
refer to meats from various sources such as meat alternatives 
from plants (tofu, seitan or tempeh) and fungi (e.g., fungal 
protein product Quorn), cell-based meat and meat from geneti-
cally modified animals.[168–169] The cell-based meat is ideally 
genetically identical to conventional animal meat; however, it 
is hard to develop due to the structural complexity. Therefore, 
efforts have been made to mimic the taste and texture of meat 
from animals by growing different cell types in coculture, on 
different substrates and in bioreactor systems. For example, 
the myo satellite or adipose stem cells can be grown in growth 
medium outside an animal in a bioreactor. These are multipo-
tent cells that can be differentiated, but need to be reharvested 
from time to time.[170] Moreover, mimicking the texture of nat-
ural meat remains challenging, and this directly and strongly 
contributes to the taste and mouthfeel of the products. In fact, 
replication of ground meat is far simpler and easier than steaks. 
Stimuli in culture is being investigated as a potential means to 
address this challenge. The first reported slaughter-free ham-
burger from laboratory-cultured meat dates back to 2013 by the 
CSO of Mosa Meat, Professor Mark Post, and it cost at that time 
≈250 000 €.[171] However, major hurdles in this field still remain 
as there is still a need to use animals as an initial source of cells 
and animal-derived serum is a basic ingredient of the culture 
media for cell proliferation and differentiation which is diffi-
cult and expensive to replace. Furthermore, this option may not 
satisfy vegetarians and vegans and the amount of meat which 
can be obtained with these methods cannot yet satisfy a global 
market.[168–169,172]
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